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SUMMARY
4
This thesis describes the application of bacteriophage displayed peptide libraries to the 
salm onid fish pathogen Aerom onas salmonicida. Antisera to both the capsular 
polysaccharide and lipopolysaccharide of A. salmonicida were used to select phage 
from 6-mer and 15-mer bacteriophage peptide libraries displayed in the p III protein of 
bacteriophage fd tet. W hen rabbit polyclonal anti-capsular polysaccharide antiserum 
was used for selection of phage from the 6-mer library, 140 phage were recovered by 
elution with glycine /HCl buffer (first round elution) and capsular polysaccharide 
solution in the second and third round of elution. Phage were amplified to high 
concentration and analysed by enzyme linked immunosorbent assay (ELISA) and the 
insert sequences detennined
Biopanning with anti-capsular polysaccharide antiserum selected a range of phage with 
peptide insert sequences which contained similar 3 to 4 amino acid motifs. The most 
predominant motif was 'serine-glycine-serine'. ELISA demonstrated that several of 
these phage bound to anti-capsular polysaccharide antiserum suggesting that these 
phage peptide sequences might antigenically mimic some capsular polysaccharide 
epitopes to which antibodies were present in the antiserum.
A monoclonal antibody to A. salm onicida  lipopolysaccharide was also used for 
biopanning with the 6-mer library and this selected phage with sequences which could 
be classified into groups, several containing identical sequences and others with similar 
motifs. ELISA assays to detect binding of these phage to lipopolysaccharide antiserum 
were inconclusive. Several selected with anti-lipopolysaccharide monoclonal antibody 
displayed peptides similar to those selected by polyclonal anti-capsular polysaccharide 
antiserum, which may reflect the similar monosaccharide composition of these related 
polysaccharides.
XV
1. INTRODUCTION
Chapter  1_______________I n t r o d u c t i o n
Commercial salmon farming in Scotland began over 30 years ago and the industry has 
developed from producing 300 tonnes of fish in 1980 to over 86000 tonnes in 1997 
(G. Rae, Scottish Salmon Growers Association, personal communication). The value 
of this product is approximately £250 million per annum and the industry now employs 
over 2000 people. Among the constraints to growth of the industry has been the impact 
of infectious diseases (Hastein, 1995), and the increasing population of farmed salmon 
serves as a ready target for infectious agents. Amongst the best known infectious 
agents are A erom onas salm onicida  (causing furunculosis), Vibrio anguillarum  
(causing vibriosis), Yersinia ruckeri (enteric red mouth disease), and infectious 
pancreatic necrosis virus (IPN, a birnavirus) (Hastein, 1995). In addition to microbial 
infections, infestation by sea lice is currently one of the greatest problems causing 
weight loss and mortalities.
1.1 Microbial Diseases in Salmon aquaculture
There are many reviews on the impact of diseases on aquaculture and Table 1 is adapted 
from Hastein (1996). It should be noted that ISA virus has recently been isolated in 
Scotland.
1.2 Furunculosis
The first documented evidence of furunculosis was over 100 years ago by Emmerich 
and Weibel 1894 (cited by Bernoth, 1997). In the winter of 1888/89, furuncle-like 
swellings that led to ulcerative lesions were noted in brown trout in a German fish 
farm. Bacteria were subsequently isolated from the ulcerated lesions and a purified 
culture of the organism  was shown to induce the same pathology as the natural 
infection when introduced into uninfected fish. The trout 'epizooty' was known to 
resemble Vibrio cholerae, and was initially named Bacterium salmonicida (Emmerich & 
W eibel, 1894). The causative organism was subsequently renam ed A ero m o n a s  
salmonicida  by Griffin et al. (1953; cited by Bernoth, 1997). Emmerich & Weibel 
described the organism as a rod-shaped, gram-negative, non-motile, facultatively
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anaerobic bacterium which was unable to grow at 37°C. They also observed that after 
a few days growth on gelatin media the organism produced a diffusible brown pigment. 
This was verified by Marsh (1902) who noted that the organism was pleomorphic with 
dimensions within the ranges 0.5-6.0 x 0 .5-1.0pm.
1.2.1 Taxonomy of Aeromonas salmonicida
Currently the species A. salmonicida is divided into subspecies: subsp. salmonicida, 
subsp. achromogenes, subsp. masoucida and subsp. smithia (Popoff, 1984; Austin et 
a l,  1989). The 'typical' strains which causes furunculosis are those o f A. 
salmonicida  subsp. salmonicida  and the rest are considered as 'atypical' subspecies. 
The atypical strains can however still cause ulcerations, as demonstrated by the (as yet ) 
unclassifed 'atypical' cytochrom e oxidase-negative A. salm onicida  isolated from 
ulcerated flounders (W iklund et a l,  1994). It has been suggested that this organism 
should be located in a new subspecies. Typical and atypical strains of A. salmonicida  
have been compared using biochemical reactions, phage sensitivity and serological 
relatedness (Paterson et a l ,  1980), however, A. salmonicida. subsp. salmonicida is the 
organism mainly discussed in this review.
1.2.2 Pathology of the disease
Furunculosis in salmon usually occurs as an acute bacteraemia, which makes the fish’s 
organs prone to colonisation by A. salmonicida  with resulting lesion formation. 
Visible lesions occur when the organism colonises the capillaries of the muscle or skin 
(Munro, 1988). There are various manifestations of the disease such as peracute, acute 
and chronic infections. In brief, a peracute infection is sudden and leaves little evidence 
of the disease; an acute infection is similar to the peracute infection but the animal 
shows increased symptoms, with the possibility of furuncle formation; finally, a 
chronic infection, which is more commonly found in older fish, is a prolonged 
infection with all the known symptoms of the disease including furuncles, leading to 
large cavities in the musculature of the fish (Munro, 1988). Fish which survive an 
outbreak of furunculosis may become asymptomatic carriers of the disease, whilst 
being apparently healthy (McCarthy, 1980). Such fish are prone to develop the disease
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under natural stress, such as during smoltification and migration to sea. Factors such as 
crowding, transport to other sites, elevated temperature and poor water quality can also 
precipitate overt furunculosis. Scallon and Smith (1985) concluded that up to 100% of 
some populations of Atlantic salmon smolts were latent carriers of A. salmonicida. The 
location of the organisms in fish harbouring A. salmonicida  in the latent state is 
uncertain, but recent work by Hiney et al. (1994) using bacteriological tests and 
enzyme-linked immunosorbent assays (ELISA) suggests that the organism is carried in 
the intestine and may also colonise the mucus, fins and gills .
1.2.3 Control of furunculosis
Various strategies have been adopted to reduce the impact of furunculosis (Bernoth et 
al., 1997), and these include improved fish husbandry, genetic selection for disease 
resistance in fish, antibiotic treatments and vaccine development.
1.2.4 Fish husbandry
The most immediate way to prevent furunculosis outbreaks in a farm is by improving 
hygiene to prevent inadvertent importation of the bacterium into the farm environment. 
This involves complete sterilisation of equipment (boots, boats, etc.) before returning 
from another fish farm, and routine disinfection of fish ova which have come from 
outwith the farm, as trout ova were found to carry the organism on their outer surface 
but not internally (Mackie, 1930, quoted by Gee and Sarles, 1942).
Another important aspect of fish husbandry is the influence of diet on the potential 
immune response of fish. An example is provided by Teskeredzic et a l (1989) of high 
mortalities of fish in Yugoslavia which could be related directly to deficiencies of 
vitamins C and B2 in the fish diet. The relationship between diet and the immune 
response of fish is further reviewed by Landolt (1989).
1.2.5 A n tib io tic  tre a tm e n t
Treatment of fish disease has for the most part relied upon the use of antibiotics, and at 
the height of the furunculosis epidemic in 1989 over 40 tonnes of antibiotics were used 
in Norwegian aquaculture, more than was used by humans in Norway (Lunestad et a l,
1992).
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Such widespread use of antibiotics has inevitably led to the isolation of antibiotic- 
resistant strains of A. salmonicida and other pathogens. For example, Brazil et al. 
(1986) isolated strains of A. salmonicida which carried an Inc U plasmid coding for 
resistance to sulphadiazine, spectinomycin, streptomycin, trimethoprim and in some 
cases tetracycline. Antibiotic treatment of fish is normally done by incorporation of the 
agent in the diet, and studies by Samuelsen (1989) showed that only 20-30 % of added 
oxytetracycline was taken up by the fish, the majority finding its way into sediments 
below the cages, where it may persist for at least 3-6 months after treatment is stopped 
(Jacobsen and Berglind, 1988).
A subsequent problem is the reported transfer of the naturally occurring tetracycline 
resistance plasmid pR A Sl to A. salmonicida in marine sediments (Sandaa and Enger, 
1994). Transfer of the plasmid occurs at higher frequency in the presence of the 
selective factor, oxytetracycline, leading to the conclusion that over-usage of antibiotics 
is increasing the occurrence of resistant bacteria. This has led to increased interest in 
other methods of prevention and treatment of disease, such as selective breeding of 
salmon with genetic traits for increased immunity, and perhaps greater resistance to 
bacterial infection (Lund et al., 1995; Marsden et al., 1996).
1.2.6 Vaccine development
W ith the increased occurrence of antibiotic resistance, the availability of effective 
furunculosis vaccines is essential. The initial success of Duff (1942) in testing an oral 
vaccine against A. salmonicida  led to the hope that an effective vaccine would be 
produced commercially. Early developments have been reviewed by Hastings (1988), 
but only in the last decade have effective vaccines been developed (Ellis, 1997) and 
these are based on incorporation of oil-based adjuvants (M idtlyng, 1996, 1997), 
despite the significant side effects, such as reduced weight gain (Lillehaug et a l ,  1992) 
and visceral adhesions (Midtlyng, 1996). Nevertheless, the effectiveness of vaccination 
programmes is shown by the statistic that in the Highland region of Scotland, smolt 
survival improved from 49% of those transferred to sea in 1991 to 96% for those 
transferred in 1993 (Munro and Gauld, 1996).
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Currently-used vaccines appear to contain killed bacteria and inactivated extracellular 
products (Ellis, 1997) and the role of iron-regulated outer membrane proteins as key 
components has been emphasised by Bricknell and Ellis (1993). A different approach 
was adopted by Vaughan et al. (1993) who constructed mutants of A. salmonicida 
which were unable to synthesise aromatic amino acids (aro mutants) and could be used 
as live vaccines. The vaccine induced an immune response in salmon with no detectable 
signs of disease (Vaughan et al., 1993; Marsden et a l ,  1996), however, this vaccine 
has not been applied commercially.
1.3 Virulence factors of Aeromonas salmonicida
A. salmonicida produces an array of potential virulence factors, some of which are cell- 
associated and some which are extracellular products (ECP). Cell-associated factors 
include lipopolysaccharide, capsular polysaccharide, a unique additional protein layer 
(A layer), and outer membrane proteins; the ECP include at least 25 proteins, of which 
the serine protease and glycerophospholipid-cholesterol acyltransferase (GCAT) are the 
most important in terms of producing the pathology typical of furnunculosis (Ellis, 
1991). Paradoxically, it has recently been shown that mutants of A. salmonicida unable 
to produce active GCAT are still virulent for Atlantic salmon, as are mutants unable to 
produce the serine protease (McIntyre et a l ,  1998). The ECP will not be discussed in 
detail but a detailed recent review of A. salmonicida ECP has been provided by Ellis 
(1997).
1.3.1 A layer
The A layer is composed of a regular tetragonal surface array composed of subunits of 
a 49 kDa protein (Tmst, 1986, 1993), and its importance in the infection is shown by 
the loss of virulence of mutants lacking A layer (Ishiguro et a l ,  1981). The A protein is 
very hydrophobic (Trust et a l ,  1983), causing auto agglutination of the organism 
(Ishiguro et a l ,  1981; Evenberg and Lugtenberg, 1982; Olivier, 1990), and is 
anchored to the cell suface by interaction with the EPS (Belland and Trust, 1985).
1.3.2 Lipopolysaccharide
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Another major antigen of the ceil envelope is the lipopolysaccharide (LPS) which is 
com prised of three m ajor units: lipid A, a core oligosaccharide, and the O- 
polysaccharide, or O-antigen. The 0-antigen chains are homogeneous in length and 
are antigenically monotypic (Chart et a l ,  1984). In conjunction with the A-protein, 
LPS appears to neutralise the normal serum bactericidal mechanisms of fish towards 
A. salmonicida (Munn et at., 1982). It has also been shown that LPS associates with 
the major lethal exotoxin, GCAT to stabilise it and enhance its activity (Lee and Ellis, 
1990). Using techniques such as méthylation analysis, periodate oxidation and proton 
magnetic resonance analysis, the structure of the O-antigen of LPS was deduced by 
Shaw et al. (1983), as shown in Figure. 1.
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F ig u re  1. T he s tru c tu re  of th e  re p e a t u n it of L ipop o ly sacch arid e . (after 
Shaw et a l ,  1983)
1.3.3 C a p su la r  p o ly sacc h a rid e
Under certain growth conditions in vitro A. salmonicida produces a slime layer or 
capsule (Garrote et a l, 1992) and this may also be expressed in vivo (Garduno et a l,
1993). It has also been shown that the possession of a capsule enhances adherence of 
the organism to, and invasion of, fish cell lines (Merino et a l ,  1996), as well as 
enhancing resistance of A. salm onicida  to killing by non-im mune serum, thus 
increasing the survival of the organism in the blood and promoting septicaemic 
furunculosis (Merino et a l,  1997; Garduno and Kay, 1995).
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Bricknell et a i  (1997) showed recently that A. salmonicida  possesses a surface 
polysaccharide which is antigenically and chemically distinct from the LPS and that can 
induce an immune response in fish. Similarities between this surface polysaccharide 
and the above-mentioned capsule suggest that they are the same component,
1.3.4 Outer membrane proteins
Proteins of the outer membrane of A. salmonicida were characterised by Evenberg et al. 
(1982), and proteins involved in iron uptake were described by Chart and Trust (1983), 
Aoki and Holland (1985) and Hirst and Ellis (1994). The iron-regulated outer 
membrane proteins are considered key constituents of vaccines protecting against 
furunculosis (Hirst and Ellis, 1994; Bricknell et al., 1996).
1.4 Use of bacteriophage-displayed peptide libraries
The purpose of this thesis was to evaluate whether phage-displayed peptide libraries 
could be used to discover peptides which might mimic epitopes present on 
polysaccharide antigens. The models chosen for this work were the lipopolysaccharide 
(LPS) and capsular polysaccharide (CPS) of A. salmonicida. Although such antigens 
can be produced readily in culture they are convenient models for other polysaccharide 
antigens which could not be produced in the quantities required for vaccines.
1.4.1 Principle of phage-display peptide technology
The filamentous bacteriophage belong to the genus of non-lytic single-stranded DNA 
phages of the Inoviridae, also known as Inoviruses (definition from Singleton and 
Sainsbui-y, 1987) and their measurements range between 760 and 1950 nm in length 
and 6 to 7 nm in diameter. The bacteriophage fd is a member of the filamentous ff 
phage which include f l and M l3. The latter two differ in genome sequence from fd 
bacteriophage by only a few nucleotides.
Phage display of foreign peptides is possible because of the architecture of filamentous 
bacteriophage, in that the coat proteins encoded by gene VIII and gene III have surface 
exposed N-terminal domains that tolerate foreign peptide inserts (Smith, 1993). Thus, 
insertion of foreign peptides into coat proteins at a suitable location, allows the inserts 
to be expressed on the outer surface of the bacteriophage. This led to the development
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of 'bacteriophage-displayed peptide libraries' where individual phage contains different 
insert sequences.
Bacteriophage fd is well suited to formation of a phage-displayed peptide library which 
can be screened to select phage which bind to a target molecule, such as a specific 
antibody, by the process of biopanning. Biopanning is the name given to the selection 
process in which phage that have an affinity for the bound target molecule are selected, 
recovered, amplified to high titre and further rounds of biopanning carried out to select 
bacteriophage which bind the target molecule with high affinity (Scott and Smith, 
1990). Selected phage can then be sequenced to identify the peptide displayed on the 
surface of the phage. The sequences determined from isolated phage are of interest 
since they can reveal the specificity of antibodies and may lead to possible mimetic dmg 
candidates. The selected phage may also prove useful in vaccine development.
The idea of developing an 'epitope library' (Parmley and Smith, 1988) was inspired by 
the work of Geysen et al. (1986) on synthetic mimotopes. In this work, peptide 
mixtures which were synthesised on plastic pins were used to bind antibodies, and this 
led to the delineation of a peptide which mimicked a discontinuous antigenic 
determinant (Geysen eta l.,{9 ^6 ). This peptide was termed a mimotope, and synthetic 
mimotope strategy was recognised as having the potential for discovery of ligands for 
antibodies whose specificity was unknown.
The work was developed by Smith (1985) by incorporation of synthesised 
oligonucleotides into the coding region of the coat proteins of the filamentous 
bacteriophage fd tet, such that a fusion peptide was expressed in one of the coat 
proteins. The related phage m l3  and fl have also been adapted for phage library 
purposes (McLafferty et al., 1993; Makowski., 1993; Felici et al., 1991; Luzzago et 
al., 1993).
1.4.2 Replication cycle of ff phage
The bacteriophage used in this project were derivatives of the filamentous phage fd, the 
structure of which is shown in Figure 2. The phage fd genome consists of a circular, 
single strand of DNA of 6408 nucleotides which is packaged in a protein sheath. The
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Figure 2. Structural organisation of the inoviruses fd, m l3 and fl.
Adapted from Kishchenko et al. (1994).
majority of this protein is comprised of the major coat protein of gene viii, called gp8 or 
gpV III. Four other proteins are also present in the virion, the distal end being capped 
with a "plug" of 5 copies of gp7 and gp9, and the proximal end being capped with 5 
copies of gp6 that subsequently bind 5 copies of gp3 to the phage structure. The N- 
terminal portion of gene iii is involved in attachment to the F-pilus and initiating 
infection (Pratt et a i, 1969; Gray et a l ,  1981). Other proteins, not mentioned here, are 
also involved in the infection process.
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Once inside the cytoplasm, the single-stranded DNA (the + strand) is converted to a 
double-stranded replicative form by the combined actions of RNA polymerase, which 
synthesizes a specific primer, and DNA polymerase III holoenzyme, in the presence of 
the Escherichia coU single-stranded DNA binding protein. The phage-encoded gene II 
protein makes a nick in the plus strand and elongation proceeds at the 3' hydroxyl end 
until a new (-k) strand is formed (reviewed by Model and Russel, 1988). The new 
strands can either act as templates for complementary strand synthesis or can be 
targeted by the gene V protein which delivers the ssDNA for production and export of 
new virion progeny.
1.4.3 Development of the phage fd Tet’
Bacteriophage fd was genetically manipulated by Zacher et al. (1979) to produce the 
filamentous phage cloning vector fd ’tet', which was possible once the entire sequence 
of fd phage had been established (Beck et a i, 1978; Schaller et al., 1978). The fd 'tet' 
vector was created by inserting the 2.8 kbp BgUI fragment from T n /0  into the BamHI 
site, near the origin of replication of phage fd. The T nW  fragment conferred the trait of 
tetracycline resistance into the intergenic region of the fd phage genome. A diagram of 
the genetic map of fd phage plus the additional TnJO fragment is shown in Figure 3. 
The structure of the phage changes by becoming longer due to the extra DNA which 
must be packaged into the final virion. This is achieved by adding an extra molecule of 
protein viii for every 2.3 nucleotides added (Kishchenko et a i ,  1994), such that the 
phage genome is extended by 2.8 kbp and the capsid contains an extra 1217 copies of 
coat protein VIII.
1.4.4 The FuseS vector
Bacteriophage fd 'tet' was further manipulated by Scott and Smith (1990) to produce 
the 'fuse' series of vectors required for the insertion of degenerate oligonucleotide 
sequences. The FuseS vector (Scott & Smith 1990) used in this project makes use of 
the coat protein gp3 which has a surface exposed N-terminal domain that tolerates 
foreign peptide inserts well (Smith, 1993). This vector was created by incorporation
-?-r
Chapter  1 I n t r o d u c t i o n 1 2
of the insert shown in Figure 4 (containing a 14 bp 'staffer region'), into gene iii of fd 
'tet' ( co-ordinates 2258 to 2263 of original fd phage; Beck et a l ,  1978) with the 
removal of 4 bp.
pfiage genes
VII D<
II V viii iii vi i■ZOl I ~ TT
intergenic 
region of fd 
coitain ing origin 
of rep iicatbn
rv
Tn10 d e rW d  region
tetA tetR
< y
irtergenic 
region cf fd
F ig u re  3. G enetic rep re sen ta tio n  o f phage fd T et'.
The location is shown of the Tn70 fragment, which carries the tetracycline resistance 
gene, within the wild type fd inovirus. Adapted from Crissman and Smith (1984).
Sfi 1 Sfi 1
5'-G G C C G A C G T G G C C T G G C C T C T G G G G C C-3''
3'-C C Q G c ITQ C a C C Q G A C C G Q  A|QA C C C C g  G-5'
Sfi 1 Sfi 1
14 bp 'staffer region'
F ig u re  4. FuseS R F  in se rt
Within the insert are Sfii restriction sites. Digestion with Sfi I creates three base long, 
sticky ends and removes a 14 bp region known as a 'stuffer region' which allows for 
the insertion of the degenerate Bgl\ (Figure. 5).
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This insert is located just downstream of the eighteen amino acid (aa) signal peptide 
sequence and disturbs the reading frame. This prevents the synthesis of gene III coat 
protein A (gp3) rendering the phage unable to infect E. c o l i , as gp3 is required by the 
phage for binding to the F-pilus of male E. coli and initiating infection of the cell 
(Boeke and Model, 1982, Model and Russel, 1988). However, fuse5 can still be 
propagated as a tetracycline-resistant plasmid independently of infection (Hanahan, 
1983; Scott and Smith, 1990).
1,4.5 P ro d u c tio n  of a 6 am ino  acid  peptide phage d isp lay  l ib ra ry  in 
Gene H I p ro te in  (gp3 coat protein)
The six amino acid phage library was made by ligating a degenerate 33 bp Bgl I 
fragment into the previously cleaved Sfil site of fuseS ( Figure 5, with the consequent 
release of the 14 bp stuffer region (Figure 4).
S'- G G  G C T ( N  N K )^G G G G  C C G  C T G - 3 '  
3 '-T G  C C C C G  A ( N N M ) . C C C C G G C  -5'
F ig u re  5. Degenerate B g ll  fragment in c o rp o ra ted  in to  fuseS.
Insertion of the 33 bp Bgll fragment restores the reading frame of gene III and when 
transfected into E.coli via electroporation (Scott and Smith, 1990) the progeny 
produce functional gene 3 protein and hence regain their infectivity.
The Bgll fragment contain the degenerate coding sequence shown as (NNK)(j in Figure 
5, with N representing an equal mixture of the deoxynucleotides T, C, G and A during 
the random synthesis of the oligonucleotide and K representing an equal mixture of G 
and T. This provides coding flexibility for 32 codons, including one stop codon, 
giving a ratio of between 1 and 3 codons per amino acid and a possible 10® different 
nucleotide sequences. The final phage peptide library contains foreign peptide inserts of 
6 amino acid with varying sequences in the coat protein gp3.
1.4.6 O th e r phage lib ra ries
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The previously discussed phage peptide library was made by insertion of foreign 
peptide inserts of 6 amino acids into coat protein gp3. Other libraries can be made by 
incorporation of larger inserts into gene III, e.g., as described for the 15 amino acid 
inserts in fuse5 vector (Scott and Smith, 1990). This library was also used in this 
project.
Other phage libraries can be made by inserting variable peptide inserts into the exposed 
N-terminal domain of the major coat protein VIII (variously nam ed pVIII, gpVIII, 
gVIIIp, p8, gp8 or g8p) which tolerates foreign peptide inserts (Smith, 1993).
Other vectors carrying additional copies of gene III or VIII have been developed to 
allow greater stability and function of the phage with larger variable regions being 
inserted. The coat protein of gene viii can only tolerate insertions of 5 to 6 extra amino 
acids (Smith, 1993), but this can be increased by having two copies of gene viii, one 
being the wild type and the other an introduced copy containing the oligonucleotide 
library. This produces progeny virions that contains a mixture of wild type gp8 and 
gp8 protein displaying peptide inserts. The insert-bearing recom binant can be 
introduced either directly into an intergenic region of the phage, or by proxy using a 
phagemid which carries the insert-bearing recombinant. When grown in the same cell 
as fd-tet phage, the progeny of the phage contains both wild type protein from its own 
DNA and recombinant protein from the phagemid. This system can also be applied to 
gene III. Figure 6 demonstrates the range of phage display vectors currently available 
using f l ,  fd and m l3 filamentous bacteriophage.
1.4.6 Constrained libraries
Constrained libraries differ from other libraries in that instead of the insert having non­
interfering small amino acids such as glycine at each end, they have cysteine residues 
at each end. This has the purpose of forcing the insert into a loop as the cysteine- 
cysteine disulphide bonding occurs. This technique was used by M cLafferty et al. 
(1993), in displaying disulphide-constrained peptides. Another example is provided by 
McConnell and Hoess (1994; 1995).
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striped a re a  s Id w s  proteins with inserts
Figure 6 . Classification of phage display vectors.
This diagram indicates the various phage vectors available using f l ,  fd and m l3  
filamentous bacteriophage. The striped areas indicate the proteins which contain 
inserts.
1.4.7 R ecen t ap p lica tio n s  of phage pep tide  d isp lay  technology 
Phage peptide display technology has recently been used successfully for displaying 
immunoglobulin variable domains (McCafferty et aL, 1990), alkaline phosphatase 
(M cCafferty et a l ,  1991), an immunogenic region of the HIV virus (Tsunetsuga- 
Yokato et a l, 1991), peptide sequences from the V3 loop of gp l20  from HIV-1 strain 
MN (Veronese et al ., 1994), and pancreatic trypsin inhibitor (Roberts et at., 1992). 
Phage peptide display technology has also been used to screen against various 
antibodies such as anti-P-endorphin mAh 3-E7 (Cwiiia et al., 1990).
I
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OBJECTS OF RESEARCH
The aim of this project was to investigate whether bacteriophage displayed-peptide 
libraries system could be used to identify peptide mimotopes which mimic epitopes of 
polysaccharides antigens of Aeromonas salmonicida. The study was divided into two 
main sections. The two antigens chosen were the capsular polysaccharide (CPS), for 
which a polyvalent rabbit antiserum was available, and the lipopolysaccharide, for 
which a mouse monoclonal antibody was available. Both the 6-mer and 15-mer 
bacteriophage libraries, displayed in protein PHI (Smith 1990), were available for use.
■;Æ
Phage isolated by biopanning were to be compared by ELISA for their binding to anti- 
CPS and anti LPS antisera and the insert sequences compared to determine whether 
particular motifs were present in the inserts.
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2. MATERIALS AND METHODS
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2.1 Materials
2.1.1 Chemicals
Unless otherwise specified all chemicals were obtained from Sigma Chemical Co., 
Poole, Dorset, U.K.
2.1.2 Bacteriophage-displayed peptide libraries
The primary (typeS) 6-mer peptide phage library (Scott and Smith, 1990), which 
contained 2 x 10^ primary dories, was provided by Professor George P. Smith 
(Division of Biological Sciences, University of Missouri). The (type 88) 15-mer 
library was produced and provided by Sam Choukri of Sm ith's laboratory and 
contained 2 x 1 0 ^  primary clones.
2.2 Amplification of the primary bacteriophage peptide library 
The method was as described by Smith (1993) with some modifications.
2.2.1 Transduction and propagation o f 6 -mer phage library in 
Escherichia coli K91kan
A 10 ml overnight culture of E. coli K91kan in LB broth (Appendix) with 100 p,g/ml 
kanamycin was shaken at 37°C overnight and 1 ml was used to inoculate each of two 
250 ml dimpled flasks containing 99 ml Terrific broth (Appendix). The cultures were 
shaken at 150 r.p.m. at 37°C until the optical density at 600nm of a 1 in 10 dilution of 
the cultures reached 0.2. At this point the shaker speed was reduced to 10 r.p.m. for 
5 min prior to the addition of 50 p i of the stock 6-mer bacteriophage library, titre 
approximately 1 0 transducing units (TU)/ml, into flask A and 10 pi into flask B.
The cultures were shaken for a further 15 min to allow infection to occur and the 
transformed cultures were then transferred to 2L flasks containing IL of LB broth 
containing 0.22 pg/ml tetracycline. The flasks were shaken vigorously for 35 min at 
37"C before addition of more tetracycline to a final concentration of 18.4 pg/ml. LB 
agar plates containing kanamycin (100 pg/ml) and tetracycline (40 pg/ml) were used to 
analyse 50 pi samples of transformed cells and untransformed cells. The plates and 
flask cultures were incubated at 37°C overnight.
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2.2.2 Purification of phage
The amplified phage-infected E. coli cultures were centrifuged at 4300 x g for 10 min 
at 4°C, the supernatants re-centrifuged at 10800 x g for 10 min at 4 “C and the final 
supernatants then transferred to three fresh 500 ml centrifuge tubes. After addition of 
0.15 vol PEG/NaCl solution (Appendix), the tubes were inverted approximately 100
...
times to ensure complete mixing. PEG/NaCl precipitation was allowed to continue for 
4 h (or overnight) on ice at 4"C. The tubes were then centrifuged at 10800 x g for 40 
min at 4°C; after discarding the supernatant the tubes were recentrifuged and the 
residual supernatants discarded.
Each pellet was dissolved in 10 ml TBS by shaking for 30 min, and the phage 
solutions were centrifuged briefly to collect them at the bottom of the tubes; they were 
then transferred to two Oak Ridge centrifuge tubes (A and B). The collected phage 
suspensions were centrifuged at 27000 x g for 10 min, the supernatants transferred to 
fresh centrifuge tubes containing 4.5 ml PEG/NaCl solution and the phage incubated 
on ice for 1 h. The phage suspensions were again centrifuged at 27000 x g for 10 min 
and the supernatants discarded. The final phage pellets were each dissolved in 1 ml of 
TBS buffer (Appendix) by shaking for 1 h. The tube was then vortexed to ensure 
complete resuspension of the pellet and the liquid was recentrifuged at 12000 x g for 
10 min, to remove any particulate material before being transferred to an Eppendorf 
tube for storage at 4°C.
2.2.3 Quantification of amplified phage
The above procedure (Transduction and propagation of 6-mer phage library ) was 
also used for quantification of amplified phage. Samples of 50 pi were removed from 
the culture and plated on LB agar plates containing kanamycin (100 pg/m l) and 
tetracycline (40 pg/ml). The plates were cultured at 37 °C overnight.
2.2.4 Repeat amplification of stock phage
A fter removing a sample from culture B for quantification as described above the 
remaining culture was incubated at 37°C overnight to allow further amplification of 
the phage in culture B, and purification (see 'Purification of phage').
7;
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2.3 Biotinylation of antiserum
2.3.1 Labelling of antibody with biotin
The absorbance of an immunoglobulin G solution of 1 mg/ml is approximately 1.4 at 
280 nm (Kabat and Meyer, 1964) and this relationship was used to establish the 
approximate protein coneentration of an immunoglobulin fraction of a polyclonal 
antiserum to the capsular polysaccharide (CPS) of A, salmonicida (kindly provided 
by Professor F. Congregado, University of Barcelona). The antiserum was then 
diluted with 0.1 M sodium phosphate buffer to a final immunoglobulin concentration 
o f 7 mg/mi (n.b. the protein concentration recommended by Smith (1993) was 10 
mg/ml).
The method for biotinylation of antiserum was provided by the manufacturer of the 
biotinylation kit (Sigma) and this is summarised below. The contents of one vial of 
biotinam idocaproate-N -hydroxy-sulfosuccinim ide ester (BA C-sulfoN H S) were 
dissolved in 30 pi dimethylsulphoxide, 0.1 ml of 0.1 M sodium phosphate was added 
to give a final volume of 0.5 ml, and the mixture was vortexed thoroughly. This 
process provided a 10 mg/ml Bac-sulfoNHS solution. Immediately, 38 p i of this 
BAC-sulfoNHS solution was added to 1 ml of the diluted anti-CPS antibody and 
mixed gently. The mixture was then shaken gently for 30 min at room temperature.
2.3.2 Isolation of labelled protein
A gel filtration column (Sephadex G-25, bed volume 9.1 ml) was equilibrated with 6 x 
5 ml volumes of 0.01 M PBS buffer. The reaction mixture was added to the column 
and the flow-through material collected as fraction one. The column was then eluted 
with 9 ml of PBS buffer (0.01 M) and 9 x 1 ml fractions were subsequently collected.
For each fraction the absorbance at 280nm was measured and appropriate fractions 
were pooled.
2.3.3 Determination of biotin/protein ratio
Method B of the manufacturer’s protocol was followed, in which 0.1 ml of the pooled 
biotinylated protein fraction was mixed with 0.9 ml 0.0 IM phosphate buffer (PB) and
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the absorbance recorded at 280 nm in a 1 cm path length quartz cuvette. This was the 
’protein sample'.
Lyophilised pronase was reconstituted with 1 ml de-ionised water, and lOpl of the 
solution was added to 0.1 ml of the pooled biotinylated anti-CPS fraction. The 
mixture, termed the 'biotin' sample, was incubated for 1.5 h at 31°C.
The lyophilised avidin was reconstituted with 19.4 ml O.OIM PB and 3.2 ml of this 
solution was mixed with 0.1 ml of 10 mM 4'-hydroxyazobenzene-2-carboxylic acid 
(HABA) solution; the absorbance of the avidin-HABA mixture was recorded at 500 
nm using O.OIM PB as a blank solution.
A mixture of 0.9 ml avidin-HABA solution and 0.1 ml of the 'biotin sample' was then 
prepared, together with a control mixture containing 0.9 ml avidin-HABA and 0.1 ml 
PB. The absorbance of both samples was recorded at 500 nm, and the biotin/protein 
ratio was calculated as shown below.
2.3.3.1 Protein concentration
From the optical density at 280nm of a 1/10 dilution of the immunoglobulin solution, 
protein concentration (mg/ml) = ODigo x 10
1.4
nmols IgG /ml= mg protein/ml x 10^
150000
assuming an average molecular weight for IgG of 150000. The factor of 10*^  is for 
conversion from moles/L to nmoles/ml.
2.3.3.2 Biotin concentration
The optical density of the avidin -HABA solution at 500 nm should be close to 1.0.
The corrected OD500 value was determined by subtracting the avidin-HABA / biotin 
value from the control mixture value.
Biotin concentration tnmols/ml) = Corrected OD<nn x 10 x 10^
E 5 0 0
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where E 500 is the HABA/avidin extinction coefficient, i.e. the A500 of a IM biotin 
solution ( = 34,000), 10 is the dilution factor, and 10^ is for conversion of moles/L to 
nmoles/ml.
2.3.3.3 B io tin /p ro te in  ra tio
The concentration of biotin molecules (nmols/ml) divided by the concentration of 
antibody molecules (nmols/ml) gives the ratio of biotin molecules per immunoglobulin 
molecule.
2 ,4 Biopanning
The following is a general description of the biopanning method and should be read 
in conjunction with the flow diagrams for each experiment.
2.4.1 C o a tin g  o f M ax i-so rp  tu b es  w ith  s trep tav id ln .
Streptavidin solution, 10 pi of a 1 mg/ml aqueous solution, was added to a Maxisorp 
tube (Nunc) containing 900 pi of sterile H2O and 100 pi of filtered IM  NaHCOg 
solution. The tube was sealed with parafilm and shaken gently overnight at 4 'C . The 
liquid was discarded and replaced immediately with blocking solution (Appendix). 
After 1 h the blocking solution was removed and the tube was washed rapidly six 
times with TBS/Tween solution (Appendix). To prevent the tube from becoming dry, 
•the next stage was initiated immediately.
2.4.2 R eac tio n  o f bound streptavidin w ith  b io tin y la ted  liga te  
TBS/Tween solution containing 1 mg/ml BSA (400 pi) was pipetted into the freshly 
prepared streptavidin-coated M axi-sorp tube and the biotinylated ligate was then 
added. Different volumes of biotinylated ligate, 10 pi and 50 pi, were added to two 
different tubes to determine the effect on phage recovery. Each tube was then sealed 
with parafilm and gently rocked at 4 “C for 4 h before addition of 4 pi of a 10 mM 
filter-sterilised solution of biotin. The tubes were rocked gently for 1 h at 4 “C to block 
any unbound streptavidin sites before washing the tubes 6 times with TBS/Tween; 
400 pi of TBS/Tween and a further 4 pi of 10 mM biotin solution were added to each 
tube to ensure blocking of unbound streptavidin sites.
2.4.3 First round of biopanning
....
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Each tube received 5 jil of the amplified library prior to being sealed with parafilm and 
shaken for 4 hr at 4 “C. Precautions were taken to ensure that the phage solution did 
not come into contact with the tube above the level coated with streptavidin and 
blocked with BSA.
2.4.4 Removal of unbound phage and elution of bound phage 
The tubes were em ptied and washed 10 times with TBS/Tween, each tube being 
tapped down onto a clean paper towel after each wash to remove any residual unbound 
phage solution. Each tube then received 400 p i of glycine/HCl elution buffer 
(Appendix) and was roeked gently for 10 min at room temperature. The eluates were 
pipetted into 1.5 ml Eppendorf tubes containing 75 pi Tris/ HCl, pH 9.1 to raise the 
pH of the eluates to the range pH 7 - pH 8.5.
2.4.5 Amplification of eluates
A mixture of 100 p i of eluate and 100 pi E, coli K91kan cells, prepared as previously 
described, was shaken gently for 20 min at rbom temperature before transfer into 20 
ml of prewarmed LB broth + 0.2 pg/m l tetracycline in a dimpled 250 ml flask and 
vigorous shaking for 45 min at 4°C.
[N.B. Titration of the input phage was also started at this point using the same batch 
of E. coli K91kan cells. Since effectiveness of transformation is strongly related to 
the bacterial growth phase, it was important to do both experiments in parallel with the 
same cells at the same time.]
After the 45 min incubation period, the concentration of tetracycline was increased to 
18 pg/ml by addition of 20 pi of a 20 mg/ml tetracycline solution. At this point, 60 
pi of the transformation mixture was removed and the remaining culture was grown 
overnight at 37°C. The 60 pi sample removed was used to provide 50 pi volumes of 
neat, 10"! and 10"^ dilutions of transformed cells which were then spread onto LB 
plates containing kanamycin (100 pg/ml) and tetracycline (40 pg/ml). As a control, 50 
pi of uninfected cells were also spread onto similar antibiotic-containing plates.
The amplified phage culture was transferred to a 50 ml Oak Ridge centrifuge tube and 
centrifuged at 5000 x g for 10 min. The supernatant was transferred to a fresh Oak
4,;.
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Ridge centrifuge tube and then centrifuged at 10000 x g for 10 min. The twice cleared 
supernatant was then mixed with 3 ml PEG/NaCl solution (Appendix) in a fresh Oak 
Ridge tube and the solution was mixed by inverting the tube 100 times. Precipitation 
of the phage was achieved by incubation at 4“C for 4 h (overnight incubation can 
increase precipitation of phage). The phage was pelleted by centrifugation at 10000 x 
g for 15 min, the supernatant was discarded and any residual supernatant was 
recentrifuged briefly and also discarded. The visible phage pellet was then dissolved 
in 1 ml TBS by pipetting and voitexing. The dissociated pellet was collected at the 
bottom of the tube by brief centrifugation and transferred to a 1.5 ml Eppendorf tube. 
The solution was then centrifuged at 15000 x g for 1 min to pellet and discard any 
insoluble matter. The phage pellet was transferred to a fresh 1.5 ml Eppendorf tube 
containing 150 [il of PEG/NaCl solution. The tube was inverted 100 times to mix 
thoroughly and then the phage was allowed to precipitate on ice for 1.5 h at 4"C.
The phage precipitate was centrifuged at 15000 x g for 10 min, the supernatant 
discarded and any residual supernatant recentrifuged briefly and also discarded. The 
final phage pellet was dissolved completely by pipetting and voitexing the pellet with 
200 pi TBS.
2.4.6 R o u n d  2 b io p a n n in g
2.4.6.1 B io p an n in g  a f te r  p re -re a c tin g  phage w ith  b io tin y ia ted  ligate 
Biotinylated immunoglobulin solution (4 pi of 5 pM  solution) was added to 195 pi of 
first round amplified phage (from the previous step) to give a final concentration of 
100 nM immunoglobulin (n.b. only a fraction of this was specific anti-CPS antibody). 
The phage and biotinylated ligate were allowed to react overnight at 4°C.
(During amplification of the 2nd round eluate the remaining 5 pi, of the 200 pi of 
amplified 1st round phage, was used to titrate the 'phage input’ into the 2nd round.) 
Follow ing overnight incubation at 4 “C, 800 p i of TBS/Tween was added to the 
reacted phage/antibody solution and the solution immediately pipetted into a freshly 
prepared streptavidin-coated maxi-sorp tube.
Removal of unbound phage and elution of bound phage were as described for l ound
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one biopanning. Amplification of eluate and PEG-precipitation of phage were also 
done using the method described for round I biopanning.
2.4.7 R ound  3 b lo p an n in g
W here appropriate, round 3 biopanning was done using the amplified eluate phage 
from round 2. The biotinylated immunoglobulin solution (anti-CPS) was mixed with 
the phage to a final concentration of 0.1 nM as opposed to 100 nM which was used in 
round 2. The lower molarity of biotinylated Ab was employed to select the phage 
binding most strongly to the ligand.
All other steps for round 3 were completed as described in round 2.
2.4.8 A naly tical ti tra tio n  of in p u t phage
This method was used to quantify the phage entering each round of biopanning.
The phage solution was diluted in TBS/gelatin (0.1 g/100 ml) solution by serial 10- 
fold dilution up to 10"  ^h A 10 pi aliquot of each phage dilution and 10 pl 'of E. coli 
K91kan cells, freshly prepared in Terrific broth, were pipetted into 1.5 ml Eppendorf 
tubes. The mixtures were allowed to incubate for 10 min at room temperature, after 
which 1 ml of LB broth, + 0.2 pg/ml tetracycline, was added to each tube. The lids 
on the Eppendorf tubes were shut tightly before placing them on their sides on a 
shaker for 30 min at 37“C. Samples of 50 pi of the infected cultures were removed 
and spread onto tetracycline/kanamycin plates (40 and 100 pg/ml, respectively) which 
were incubated overnight at 37“C.
2.4.9 B iopann ing  a 6-n ier phage lib ra ry  w ith  an ti-C P S  an tise ru m
The previously described method was applied to the first set of three rounds of 
biopanning with CPS Ab as depicted by Figure 7. A repeat of this experiment differed 
in the second round where CPS (120 pg/400 pi) was used as the eluant rather than 
glycine/HCl buffer. This strategy was used in an attempt to enhance the selection of 
phage that mimic CPS. This method is depicted in Figure 8. The experiment led to the 
isolation of 40 phage clones which were eluted by glycine/HCl in the first round and 
CPS in the second round. The phage were subsequently purified for ELISA and 17 
subsequently sequenced.
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The second round eluate from the above biopanning experiment was further amplified 
as shown in Figure 9.
2.4.10 Biopanning with a 6-mer phage library and biotinylated  
monoclonal antibody to Aeromonas salmonicida LPS
2.4.10.1 Processing and biotinylation of anti-LPS monoclonal 
antibody
A monoclonal antibody (MAb) against the lipopolysacharide of A, salmonicida  , 
which had been prepared by Mrs. Julia Dunlop during a previous project, was used. It 
was termed F9 clone 16 and was supplied as 45 ml of tissue culture (hybridoma) 
supernatant fluid which had been purified by protein G (Pharm acia) affinity 
chromatography. The solution was concentrated by dialyis against PEG 20000 for 4 
h, after which time the contents of the dialysis sac, 1.75 ml, were recovered and the 
tubing washed out using a further 0.5 ml saline buffer. The total volume of 2.25 ml of 
concentrated anti-LPS MAb contained 4.2 mg/ml protein and it was biotinylated as 
previously described (Section 2.3).
2.4.10.2 Biopanning of the 6-iner phage library with biotinylated anti- 
LPS monoclonal antibody.
Biopanning was carried out as described above (Sections 2.4.1 to 2.4.7) and the 
protocol is summarised in Figure 10. At various stages of the biopanning process, 
colonies were selected from the plates and the phage amplified and purified (see 
previously described method). The selected phage were assayed by ELISA using 
method C (Section 2.6.4).
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2 .4 .11  B io p a n n in g  w ith  a 1 5 -m e r p e p tid e  l ib r a r y  and anti-LPS 
monoclonal antibody
2.4.11.1 C en trico n  f il tra tio n  o f e lua te  from  ro u n d  one biopanning 
Biopanning with the 15-mer phage library was carried out as for the 6 mer library. In 
the first round of biopanning 10 pi of biotinylated anti-LPS MAb was used along with 
5 pi of 15-mer stock phage library. Duplicate tubes were used in Round 1 and the 
bound phage was eluted with glycine/HCl buffer. One of the two eluates from Round 
one was concentrated using a 30 kDa Centricon filter and the recovered phage 
suspension amplified. The resulting 200 pi amplified phage suspension was divided 
between two streptavidin coated Maxi-sorp tubes for the second round of biopanning.
2.4.11.2 B io p an n in g  R o u n d s tw o an d  th ree
The following flow diagram (Figure 11) indicates all three rounds of biopanning, 
including round one described above. At the end of round three , 40 clones were 
selected and the phage amplified and purified as previously described. These clones 
were assayed by ELISA and the insert DNA sequences of 5 phage derived from tube 
12 were determined.
2.5 P ro p ag a tio n  an d  processing  of phage on a sm all scale 
Individual colonies were picked from the plates and cultured separately. Tubes (18 
mm X 150 mm) containing 1.7 ml LB broth + 20 pg/ml tetracycline were inoculated 
with individual colonies and incubated at 37°C overnight. The cultures were 
transferred to 1.5 ml Eppendorf tubes and the cells pelleted by centrifugation at 20000 
X g for 10 min. A 1 ml sample of supernatant was then transferred to a fresh 
Eppendorf tube containing 1.5 ml PEG/NaCl solution and tubes were inverted 100 
times to mix the solution thoroughly. After incubation on ice for 4 h the precipitate 
was collected by centrifugation at 20000 x g for 15 min, the supernatant discarded, 
and the phage pellet was dissolved in 500 pi of TBS by vigorous vortexing.
Chapter
GZ
©OJ)G 1 1G3 <u bJOA toû • g
§
G Gd
s G G
u z GZ Ocov 4 G 3•GG Td
1
§o 1G eu Gm
" g
O
Ô G 4—»Æ OX S G
a y dG G ' g
"g Td
"S
3
d
3
>
3
u o ÇQo p G
d Who p Pa 3 Ga Gc o
;
3oGZ
p
1+2 od Ç PG g Td. GT ) Td O© G o- y G pG O co
>% t-H 3
. S 3 8'W p
33 s
B 3toi) ud Td
M
d & iGd VhtoJ) pH ad O
• p
■p
G G tzQ h OO Vh
x s 2«w £ pO 3{/]OT" d G§ OGZ Pd co pH2 I
t4—1B
P t-Heu 5P uP
Æ
G
3H co .1f—c g
b ûeu S-Hp b O
& a P h3 a X
&
O
<I
I8
1
I
o
5
GZ
I
<DI
d>
I
O
voCO
6%
'801cc
(DCO
M a te r ia l s  and M ethod s 3 1
zl0
G10
(U1
( NTdI
B
A
■s IIs
8
§ X
3 S3 P3 . G <PVd 1 gOp -
_ c i 1Td o pp
3 p G
3 g bûp G
% 3G
'â B 3 .
p (N oG (N o1 3
A
CO
5
§
Iom
Td18
2
+ 3
p
GO B o
O P h H
3 P p6
m
G
% 1
8
<
1
3L
8
O C OTdG
§
I
A
Td
(U!
A
1
cN
C O
gI
y 5
GZ
A
CO
5
mo
X
H
I
8
^  CO
§  5
GZÇg GZ
CNI
G
TdGCN
+
P h  t 3  2
GZpH0
Td1
o
( N  -
o P 2vS CD VO co co r i
VO O o CNO
<N
O h3 3 3o o +-J P pP CN co co1 p ’-H (N P p pp p P P P W 5P 5Pbû bû bû bû bû G 2 GG G G G G P p PP P P P P P p PpH Ph Pn P P P p PP P P P P > > N> > > > > G G GG G G G G bû bû bûbû bû bû bû bû O T—H <NVO P IN OO o\ t-Hp P P P P P <D Pp P P p P P p PG G G G G G G GH H H E-r H r i r i r i
A
$  ^Idfd CN 
CNI ^
: :
<D
^  'g
P h a  
T d 'U G  ÇUI I
A
CO
CP
11Td ^  p  CNCOsI
g> m (D IN'
IITd PII
%
P ooTd pG GG GP N-c/)
.8 PG 3O 3P pp P pP pG P pP P pP P oO 2 2
â p a
Td ’—: (NGG PP .8O G GS-H ri ri
O
(N
V )
&I
OO
*0
13
B
<
%
i
$
ÎII
I
..Ï:
Chapter 2 M a te r ia l s  and M e t h o d s__________________ 3_2
2.6 ELISA Procedures
Various ELISA methods were used with each set of phage selected for analysis, with 
differences in the materials used to coat microtitre plates and in the detection systems.
The main methods used are described below. Methods A and B were first applied to 
the CPS clones obtained from the previously described experiments. I
2.6.1 Purification of phage for ELISA
The phage suspension (Section 2.5) was centrifuged for 1 min at 20000 x g to pellet 
any insoluble matter and the supernatant was transferred to a fresh 1.5 ml Eppendorf 
tube containing 75 pi PEG/NaCl solution. After thorough mixing by inverting the 
tube 100 times the suspensions were incubated at 4°C for 4 h, then centrifuged at 
20000 X g for 15 min, the supernatant fluid removed and any residual fluid removed 
after further centrifugation for 1 min. The pellet was dissolved in 0.15 M NaCl by 
vigorous vortexing; insoluble matter was pelleted by centrifugation for 1 min at 20000 
X g, and the supernatant was transferred to à fresh Eppendorf tube which contained
11.1 pi IM  acetic acid. The fluid was mixed thoroughly followed by incubation for 
10 min at room temperature, and an additional 10 min on ice, after which the phage 
were collected by centrifugation at 20000 x g for 30 min at 4 “C and the supernatant 
discarded. Any residual supernatant fluid was discarded after brief centrifugation.
The phage pellet was dissolved in 200 pi TBS (sometimes 500 pi) and insoluble 
matter was removed as described previously.
2.6.2 Method A
This method was used for selected phages from the second round of biopanning with 
polyclonal anti-CPS antiserum. The phage were eluted with glycine/HCl buffer in the 
first round and CPS (120 pg/ml) in the second round.
Flat bottomed 96-well ELISA plates were used for all experiments and each clone was 
assayed in duplicate. After dispensing 40 pi phage suspension per well the plate was 
covered and placed at 4“C overnight before rinsing each well by pipetting 200 pi 
blocking solution (see Appendix) into each well and removal with a Gilson pipette.
Wells were then blocked with 350 pi of blocking solution overnight at 4 “C.
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The blocking solution was rem oved and the wells w ashed three tim es with 
TBS/Tween (0.5 % v/v Tween 20). Each well then received 35 pi biotinylated anti- 
CPS antibody (30 nM solution in TBS/Tween + BSA 1 mg/ml). The reaction was 
completed overnight at 4“C, after which the ligate solutions were removed and the 
wells washed seven times with TBS/Tween and once with TBS. Biotinylated anti­
rabbit antibody solution (35 pi, 5 pg/ml) were added to each well and allowed to 
react at 4°C overnight. The plate was washed a further seven times with TBS/Tween 
and once with TBS. Each well received 85 pi Horseradish Peroxidase Avidin D 
(HRP-avidin; Vector laboratories, Cat. No. A-2004) (diluted in TB S/0.1% Tween)
and the plate was incubated for 30 min at room temperature. The plate was then 
washed seven times with TBS/Tween and once with TBS. Finally each well received 
85 p i of freshly prepared ABTS peroxidase substrate solution [2,2'-Azino-di-(3- 
Ethyl-Benzthiazoline sulphinate) 6] (Dynatech Laboratories) and after incubation for 1 
h at room temperature the optical density of each well was measured at 405 nm at an
equal time after the addition of the substrate. The readings were compared to the 
control readings at 492 nm but it was not deemed necessary to deduct these values, 
from the test values, since no abnormal readings were found at 492 nm (see Controls 
section below).
Appropriate controls were included for each step; where phage was omitted, an equal 
volume of TBS was used in it place. Other controls used were TBS instead of 
biotinylated antibody, biotinylated anti-rabbit antibody and avidin. Purified CPS was 
also added in place of phage at concentrations of 10, 1, 0.1 pg/ml. Stock phage was 
also assayed at various concentrations (neat, 1/ 3 , V l O ,  V s i ,  V l O O  i »  TBS) in place 
of selected phage clones.
2.6,3 M eth o d  B
This method was used for analysis of selected clones from the second round of 
biopanning using polyclonal anti-CPS antibody. Initial steps and volumes used were 
as in Method A, except that only 40 pi HRP-avidin solution in TB S/0.1% Tween was 
used. The optical density of each well was read as described previously
I          : : :   -
''I:
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2.6.4 M eth o d  C
This was used for phage selected from the 6-mer library in the three rounds of 
biopanning using biotinylated anti-LPS MAb. Phage from each clone were assayed in 
duplicate in 40 pi volumes as described in ELISA Method A (Section 2.6.2), except 
that biotinylated anit-LPS MAb (50 nM in TBS/Tween with BSA, 1 mg/ml) was used. 
After 15 h at 4°C the ligate solutions were aspirated from the wells, which were then 
washed ten times with TBS/Tween and once with TBS. Each well received 35 pi 
HRP-avidin solution (Vector Labs ABC reagent) diluted in TB S/0.1% Tween. The 
plate was incubated for 30 min at room temperature before being washed seven times 
with TBS/Tween and once with TBS. Finally, each well received 85 pi of freshly 
prepared ABTS solution and after reaction at room temperature the optical density of 
each well was read after 5 min and 60 min as described previously.
2.6.5 E ffec t of p h ag e  co n ce n tra tio n  on th e  E L IS A  resp o n se  
Clones 1 and 2 (high binding phage) and clone 6 (low binding phage) were selected 
and serial dilutions (neat, I/3 , VlO, V3 I, VlOO) were made in TBS. Each dilution 
was then assayed with the ELISA described in method B.
Clones 5, 18 and 28 (high binding phage) and clones 25 and 26 (low binding phage) 
were also assayed (6 wells per clone) at a dilution of 1/6 in TBS.
2.6.6 C om p e titiv e  E L IS A
The high binding phage 1, 5, 28, 40 and low binding phage 6 and 26 were re­
amplified and purified for this experiment. Prior to the addition of the biotinylated 
antibody (method B) selected wells received 35 p i of CPS at five different 
concentrations (10, 3.2, 1, 0.32 and 0.1 pg/m l). Standard controls were applied 
(dilutions of stock phage, no avidin, no anti-CPS, and dilutions of CPS).
2.6.7 B ind ing  p ro p e rtie s  of ca p su la r  po ly sacch arid es  to  E L IS A  p la tes  
The binding of CPS was tested at pH 5, 6, 7, 7.5, 8, 9, and concentrations of 320, 
160, 80, 40, 20, 10, 2.5, and 0 pg/m l CPS (diluent was TBS with acetic acid or 
sodium bicarbonate solution for pH modification). The ELISA was performed using 
method B except that CPS was used in place of phage.
C h a p te r  2  M a t e r i a l s  a n d  M e t h o d s
2.6.8 ELISA for phage
Phage suspensions were analysed by ELISA using HRP-conjugated anti-M IS 
antibody ( Pharmacia, product No. 27-9402-01). The method was as described for 
anti-CPS except that the HRP-anti-phage antiserum was added in place of the anti- 
CPS. The reaction was allowed to proceed for 14 h at 4°C followed by 10 washes 
with TBS. After addition of substrate, the plate was incubated and the absorbance read 
as previously described.
2.7 Sequencing
2.7.1 Preparation of DNA samples
To 200 pi of phage from small scale propagation and purification was added 200 pi of 
phenol / chloroform (1:1 v/v). The solution was thoroughly mixed by vortexing, 
centrifuged for 15 min at 15000 rpm and the aqueous phase transferred to a fresh 1.5 
ml Eppendorf tube which contained 250 pi TE buffer. This solution was mixed with 
40 pi 3M sodium acetate solution, 1 ml ethanol was added with mixing and DNA was 
allowed to precipitate for 1 h at - 20°C. The precipitated DNA was pelleted by 
centrifugation for 30 min at 20000 x g. The supernatant fluid was aspirated from the 
tube, discarded and the DNA washed once with 1ml 70% ethanol (carefully applied 
down the centripetal wall of the tube). The tube was centrifuged at 20000 x g for 8 
min and the supernatant discarded; the pellet was washed once more with 1ml 70% 
ethanol and the supernatant discarded as before. The final product was dissolved in 7 
pi water.
2.7.2 DNA agarose gel electrophoresis
Gel preparation and sequencing procedure is described in the Appendix.
2.8 Electron Microscopy
From an overnight culture of uninfected E. coli K91kan cells a sample of 100 pi was 
mixed with 10 p i of formalin. After 1 h, 50 p i of the mixture was collected by 
centrifugation and washed 3 times with PBS to give a final volume of 50 pi. An 
overnight culture of phage-infected E. coli K91kan cells was processed similarly
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The samples were analysed at the University of Glasgow IBLS Electron Microscopy 
unit with the assistance of M argaret Mullin using a Zeiss 902 transmission electron 
microscope.
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3.1 Amplification of primary bacteriophage peptide library
When amplifying a primary bacteriophage peptide library it is necessary to calculate the 
concentrations of the phage used for infection and the phage recovered (see Methods 
section for explanation of calculations). Whilst good amplification can maintain an 
effective library, poor amplification can damage the effectiveness of a library by 
reducing the diversity of inserts available.
3.1.1 Growth of E, co li K91kan in broth culture
The host bacterium used for amplification of the filamentous bacteriophage fd tet 
peptide library was E. coli K91kan. The f-pilus structures on the surface of the 
bacterium are recognised by the minor coat protein III of the fd phage, leading to
V-'
infection of the organism. For optimum replication of the phage it is essential that they 
are introduced into the E. coli culture when cells carry the greatest number of fully 
formed F-pili and hence are most susceptible to infection. According to Smith (1993) 
the best potential for infectivity occurs during late exponential growth when a 1/10 
dilution of the E. coli K91kan culture reaches an optical density (OD) of 0.2 at 
600nm.
Figure 12 shows duplicate growth curves of E. coli K91kan and demonstrates the
k
consistency of growth of the organism when all other growth parameters remain 
constant. This proved useful when preparing cells for infectivity^and planning of 
experiments. From the results shown in Figure 12, an absorbance of 0.2 (at a 1/10 
dilution) was reached within 4 h, and it was feasible to leave cultures to grow 
unattended for a period of 3 h, before regular monitoring until the appropriate
::
absorbance was reached. This was at approximately 3h 40 min after establishing the 
culture.
3.1.2 Amplification
Two separate amplifications were done from the initial library (Experiments A and B), 
followed in Experiment C by further amplification of the product of Experiment B.
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F ig u re  12. G ro w th  cu rve  fo r E. coli K91 k an  in  LB b ro th  
Prewarmed LB broth, 100 ml in each of two 250 ml dimpled Erlenmeyer flasks^was 
inoculated with 1 ml of an overnight culture of F. coli K91Kan. The cultures were 
shaken at 200 oscillations per min at 37°C and the absorbance at 600nm of a 1/10 
dilution of cultures measured at regular intervals for up to 3 h 40 min.
Absorbances shown are of 1 in 10 dilutions of the cultures.
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3.1.3 Experiment A
In the first amplification (Experiment A) SOjil of stock phage was used to infect E. coli 
K91kan, and the titre of the phage suspension was determined as 2.6 x 10^^ TU/ml,
Icorresponding to 7.15 xlO^^ virions/ml, assuming an efficiency of TU determination 
of 4 % (Smith, 1993). Thus, there were 3.6 x lO^o virions in the 50pl inoculum, and 
the number of phage recovered was 3.3x10^0 virions in a volume of 1 ml. The
■famplification factor in this experiment was 0.9, i.e. a reduction in titre and thus an
'funsuccessful amplification step. y
3.1.4 Experiment B fIn this experiment 10 fll of phage (1.8 x 10^^ virions) was used as inoculum for 
amplification; 1.1 xlO^^ virions were recovered in a volume of 1 ml, corresponding to 
an amplification factor of 6, despite a reduction in phage concentration from the 
starting level of 1.8 xlO^^ virion/ml to 1.1 xlO^^ virion/ml.
3.1.5 Experiment C
The phage from experiment B would be suitable for biopanning, however, it was " "•considered that greater amplification should be achievable, and a repeat amplification
was performed on the product of Experiment B. The 10 pi input phage contained 1.1 &
IxlO^ virions which yielded 8.25 xlO^  ^ virions in a volume of 1 ml.The amplification f
tfactor of 750 was acceptable and this phage stock was used in subsequent biopanning
"texperiments.
r:i3.2 B io tin y la tio n  o f ra b b it  an ti-C P S  antiserum
An immunoglobulin fraction of rabbit anti-A. salmonicida CPS anti serum, prepared J
by ammonium sulphate precipitation, was diluted to a protein concentration of 7 mg/ml
for labelling with biotin. After biotinylation the labelled protein was separated from free
biotin by gel filtration. The elution profile from the column is shown in Figure 13. 7
Fractions 4 to 7 were pooled together to give 4 ml of biotinylated antibody solution,
1calculated from A280nm measurement to contain 0.82 mg/ml protein (5.5 nmole
IgG/ml). j;
. A
Chapter 3 Results 40
E l u t i o n  P r o f i l e
N
I
©
<
1.4
1.3
1.2
1.1
1.0
0.9
0.8
0.7
0.6 i
0.5
0.4
0.3
0.2
0.1
0.0
fractions
T—Y—I—I—r—I—r f I—I—-j~ T-1—I
0 1
Fractions
Figure 13. Separation of biotinyiated anti-CPS Immunoglobulin from 
free biotin by Sephadex G 25 chromatography.
One ml biotinylated immunoglobulin reaction mixture from rabbit antiserum to A. 
salmonicida CPS was applied to a column of Sephadex G25 Fractions of 1 ml were 
collected and the absorbance at 280nm measured. Fractions 4, 5, 6 and 7 were 
combined to give 4 ml of biotinylated antibody. Free biotin was eluted in subsequent 
fractions (not shown).
•i.
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The concentration of biotin in the solution was determined to be 40.6 nmol/ml (see 
Methods section for details of calculations), giving a ratio of 7.4 biotin molecules per 
antibody molecule. Such a ratio is satisfactory to achieve adequate binding of antibody 
molecules to the streptavidin-coated tubes.
3.3 Biopanning with biotinylated rabbit-anti-CPS antiserum
A schematic diagram of the biopanning done in Experiments 1 and 2 with biotinylated 
polyvalent anti-CPS antiserum is shown in Figures 7 and 8. The quantities of phage 
applied and recovered in all experiments with anti-CPS antiserum and the 6-mer library 
are summarised in Table 2.
3.4 Analysis by ELISA of phage selected by blopanning with anti-CPS 
antiserum
3.4.1 Comparison by ELISA of the interaction with anti-CPS antiserum
■of phage selected by biopanning
'
Forty separate clones selected from the eluate of tube A (round 2) (see Table 2) were
:amplified, the phages purified and used for ELISA. The results (Figure 14; 39 clones 
shown) indicated a high background absorbance value for the control phage (the stock 
phage library); this was thought to be due to the use of a biotinylated second antibody 
(anti-rabbit IgG anti serum) as well as biotinylated first antibody (rabbit anti-CPS 
antiserum). The experiment was repeated omitting the biotinylated anti-rabbit IgG 
reagent to produce the results shown in Figure 15. The background absorbance of <
0.1 at 405nm was more satisfactory and gave greater discrimination between high and 
low binding phage compared to the results shown in Figure 14. With the exception of 
phage 40 (not tested in the first experiment) and phage 39, those phage which gave an 
absorbance value > 0.01 above background in Figure 15 gave an absorbance above 
background in Figure 14. This consistency suggests that there had probably been 
selection of phage with an affinity for anti-CPS antibody.
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Figure 14. ELISA of 40 isolated phage selected by 
biopanning a 6-mer library with anti-CPS antiserum.
The ELISA reaction was terminated at 35 minutes.
The 1st round elution was with glycine/HCl and the 2nd round with 
CPS (120 [ig/400 ml). The background reading is shown by the 
solid line. This ELISA involved an amplification step using 
biotinylated anti-rabbit antibody.
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Figure 15. ELISA of 40 phage selected by biopanning 
with anti-CPS antiserum.
The microtitre plate was coated with purified phage (in duplicate 
wells) and subsequently treated with biotinylated rabbit anti-CPS 
antiserum, and biotinylated goat anti-rabbit IgG antiserum. 
Development was with HPR avidin and ABTS. The reaction was 
terminated after 8 minutes. Phage used were selected from the 6- 
mer library with biotinylated anti-CPS antiserum. The absorbency 
values for each phage have also been placed above the 
corresponding bars.
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3.4.2 Reproducibility of ELISA using bound phage and anti-CPS 
antiserum
To determine the reproducibility of the ELISA method using anti-CPS antibody and 
microtitre-plate-bound phage, three putative high binding phage (5, 18 and 28) were 
assayed along with two low binding phage (25 and 26) using six wells per phage. The 
results shown in Figure 16 indicate marginal differences, demonstrating the consistency 
of the ELISA assay. This is confirmed in Table 3 where the mean and standaid 
deviation of 6 replicate samples is given for each of the phage tested.
3.4.3 Effect of phage concentration on ELISA
To determine whether the amount of phage used for coating the ELISA plates might 
affect the subsequent A405nm> phage from clones 1, 2 and 6, representing 2 putative 
h ig h ’ and 1 putative 'low' binding affinity phage, respectively, were used to coat wells
Table 3. Mean and standard deviation for the ELISA absorbance values 
for phage 5, 8, 28, 25 and 26 selected by biopanning with anti-CPS 
antiserum.
Absorbance (nm)
Phage number  mean (n = 6) _____ Standard deviation
5 0.430 0.023
18 0.343 .0019
28 0.385 0.030
25 0.153 0.007
26 0.150 0.020
Figure 16. Determination of tbe reproducibility of the 
ELISA for binding of phage by anti-CPS antiserum. T he
binding of phage 1,18,  25, 26, and 28 was compared (6 wells per 
phage) and the reaction was terminated after 60 minutes.
The dotted line shows the mean absorbance value for the duplicate control 
wells containing TBS instead of phage.
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of an ELISA plate at dilutions from neat to 1/100. Figure 17 shows the relationship 
between concentration of phage and ELISA absorbance. TBS buffer was used as a
, f-control and, as expected, the absorbance values for phage 6 at all dilutions were similar 
to those of the TBS control. For phage 1 the absorbance reading remained relatively 
constant up to a dilution of 1/10 and for phage 2 a dilution of 1 in 10 reduced the 
absorbance to background level (Figure 17).
3.4.4 Competitive ELISA
The competitive effect of purified CPS on the ability of the CPS antibody to bind to 
four phages which showed high binding in the ELISA (5, 2, 40, and 1 ; Figure 15) and 
two which showed low binding (6 and 26; figure 15) was investigated. Various 
concentrations of CPS were included with anti-CPS antiserum exposed to phage bound 
to the wells of the microtitre plate. Control wells gave the expected background OD at
405nm of approximately 0.1 (Figure 18). The high binding phage all gave absorbance 
values > 0.2 in the absence of CPS, and the low binding phage 26 gave a value similar
to the background. However, an unexpected result occurred with phage 6, previously 
shown to be a low binding phage, which in this experiment gave an absorbance of 
0.18 OD, a value similar to those of the high binding phage 2, 40 and 1. Since all the
phage selected for this experiment had been re-amplified to produce sufficient material 
for the experiment, it is possible that phage 6 had not been properly amplified for 
previous experiments (Figure 15). Addition of CPS did not inhibit binding of antibody
.to the bound phage in a dose-dependent manner, although phage 5, 6, 2, and 40
showed maximum inhibition with CPS concentrations of 1 or 0.32 |_ig/ml (Figure 18). 
When CPS was bound to the microtitre plate for ELISA low absorbance values were 
found (far right of Figure 18), indicating either weak interaction between CPS and anti- 
CPS or poor binding of CPS to the plastic wells (see next section).
3.4.5 B ind ing  of CPS to  m ic ro titre  p la tes  a t  d iffe re n t pH  
The bicarbonate buffer normally employed for coating microtitre plate wells with 
antigen is designed for use with most protein antigens, but polysaccharide antigens
Figure 17. ELISA using various dilutions of phages of 
1, 2 and 6 selected with biotinylated anti-CPS 
antiserum.
The TBS control (background level) is shown as a dotted line on the 
graph. The ELISA was terminated at 60 minutes. Phage 1, 2 and 6 
were selected as representatives of all the phage isolated by 
biopanning.
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Figure 18. Effect of CPS on the binding of phage to 
anti-CPS antiserum.
Four phage (5, 2 ,4 0  and 1) with putative high affinity binding to 
anti-CPS antisera and two (phage 6 and 26) of putative low affinity 
for anti-CPS antiserum were tested by ELISA for their ability to 
bind anti-CPS antiserum in the presence of 0-10 mg/ml CPS 
solution
Controls (from left to right) no phage, stock phage, (neat, 1/3, 1/10, 
1/32), no antibody and no HRP. The average of these controls is 
indicated as a dotted line on the graph.
For clones 5, 6, 2, 40, 1 and 26. from left to right,
CPS was added to a concentration of 10 pg/ml, 3.2 pg/ml, 1 pg/ml, 
0.32 pg/ml, 0,1 pg/ml, 0.0 pg/ml respectively.
CPS was used to coat certain wells of the microtitre plate instead of 
phage: concentrations used were (from left to right) 10 pg/ml, 
3.2|ig/ml, 1 pg/ml, 0.32 pg/ml, 0.1 pg/ml.
Chapter 3 Res ul ts 49
£U
\ofN0>co
oTt<uCo
fNIVCo
soQJa_o"v
irjo>BO
rcv^ v^ '.v^ vvvi^ kikkk^ kkLkTv
o
T
O
T -If)
s o p y
Chapter 3___________________ Results_____________________  50
often require different conditions for binding to occur. In this experiment the 
concentration of CPS was varied from 2.5 to 320 jiig/ml and the buffer pH was varied 
from 5 to 9 to determine the effect on binding of CPS to ELISA plates. After deduction 
of background values it was apparent that absorbance values were still relatively low, 
but greatest binding occurred, on average, at pH 9 and was proportional to CPS 
concentration (Figure 19).
3,5 Determination of insert sequences
.
3.5.1 Phage selected after two rounds of biopanning with anti-CPS 
antiserum
Of the 40 phage analysed by ELISA (section 3.4), 17 were purified for sequence
determination and the results are summarised in Figure 20. Representative examples of
the sequencing lanes seen on the autoradiograph are shown in Figure 21 for phage 28,
■29 and 36. From ELISA experiments 13 of the phage had been categorised as high 
binding clones and 4 as low binding.
It is interesting to note that 10 of the 17 phage have the initial insert sequence of 
'GLY-SER-GLY', and that two such phage (14 and 20) were considered low binding 
clones. Clone 40 of the high binding group was found to have only a 6 nucleotide 
insert, clearly seen in Figure 22, and the 2 amino acid insert was GLY-SER', 
corresponding to the initial sequence found for the above group of 10 phage.
Figure 19, Effect of pH on binding of CPS to microtitre 
plates for ELISA.
The control to which no CPS was added, are shown separately.
CPS at concentrations up to 320 jxg/ml was used to coat the wells of 
a microtitre plate in buffers of pH 5 to pH 9, prior to reaction with 
biotinylated anti CPS antiserum and HRP-avidin.
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Figure 20. DNA and protein sequences of inserts from phage selected 
after two rounds of biopanning with CPS antiserum and the 6-mer phage 
library. Phage bound in the first round of biopanning were eluted with glycine/HCl 
buffer and from the second round with CPS (see Table 2). From the ELISA results 
(Figures 13 and 14) the phage were categorised into groups with high or low binding 
affinity. Note that an identical sequence of amino acids can arise from a different genetic 
code. The ? symbol indicates that it was difficult to read the nucleotide sequence from the 
autoradiograph.
HIGH AFFINITY BINDING PHAGE
Phage A m ino acid
number sequence genetic code
31 GLY SER GLY ALA HIS TRP (GGT TC T  G G G  G C T CAT TG G )
3 9 GLY SER GLY ALA HIS TRP (G G T T C T  G G G  G C T  CAT TG G )
3 GLY SER GLY ALA ARG LEU (GGT T C T  G G G  G C T  CG G  CTT)
28 GLY SER GLY GLY MET ASP (GGT T C T  G G T  G G T A TG  GAT)
13 GLY SER GLY ARG ASP ALA (GGT T C T  G G G  CG T AAT G C T)
4 GLY SER GLY SER ARG THR (G G T T C T  G G G  A G T C G T  ACG)
2 GLY SER GLY PRO VAL ASN (G G G  T C T  G G T  C CG  G TT AAT)
5 GLY SER GLY PRO ALA VAL (GGG T C T  G G G  CCG  G CG  GTT)
1 GLY THR GLY SER TRP GLY (GGT ACT G G G  T C T  TG G  G G T)
3 6 MET PHE SER LEU ILE PRO (ATG T T T  T C G  C TT A TT CCT)
18 PRO TYR SER PRO HIS LEU (C C G  TA T A G T C C T CAT CTG )
29 SER GLN ALA ARG SER GLY (TCG  CAG G C T  CG T T C T  G C T)?
40 GLY SER (GGT AGT) (2aa INSERT)
LOW AFFINITY BINDING PHAGE
14 GLY SER GLY GLY GLU HIS (G G T T C G  G G G  G G T  G A G  CAT)
20 GLY SER GLY GLY GLU HIS (G G T T C G  G G G  G G T G A G  CAT)
8 SER SER MET LEU PRO PRO (TCG  T C G  A TG  CTG  C C T C CT)
32 SER GLN ASN LEU ASN GLU (TCG  CAG AAT C TT AAT GAG)?
Chapter 3 Resul ts 53
clone 28 clone 36 
T C G A
INSERT
clone 29
FIGURE 21. Example of an autoradiograph for nucleotide sequence 
determination.
DNA extracted from phage was used for nucleotide sequence determination. The 
results for phage 28, 29, and 36 selected from the 6-mer library by biopaning with 
biotinylated anti-CPS antiserum are shown. The insert is located between the arrows as 
shown.
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T C G A
INSERT
FIGURE 22. Autoradiograph showing the 6 nucleotide insert sequence 
of phage 40, selected with anti-CPS antiserum
Phage 40 was selected from the 6-mer phage library by biopanning with anti-CPS 
antiserum, being eluted by glycine/HCl in the first round of biopanning and CPS in the 
second round. The six base insert (coding for 2 amino acids) is located directly above 
the middle group of 4 cytosines. All other phage selected from this round contained a 
DNA insert coding for six amino acids.
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3.6 Repeat amplification of second round eluate and further biopanning 
using anti-CPS antiserum and CPS as the elutant, to produce a third 
round eluate.
To further refine the selection of phage from the two rounds previously described the 
phage recovered in the second round were re-amplified and taken through a third round 
of biopanning with the biotinylated anti-CPS antisemm and CPS solution as the elutant. 
The titre of phage used in round three (Table 2.) was calculated to be 
1.3 X IQi^ virions/ml with an actual input of 1.27 x 10^4 virions for the 98 pi added.
The titre of the recovered phage (Table 2) was 2.9 x 10'^  and 1.9 x 10"^  virions/ml for 
tubes A and B, respectively, with a total yield of 1.4 x 10^ and 9 x 10^ virions, 
respectively. The percentage yields for the third round of biopanning were 1.1 x lQ-5 
and 6.9 x 10'*^  % for tubes A and B. These low values may be due to the reduced 
amount of antibody used in this round in order to promote competition and selection of 
phage with the highest binding affinity. It may also be that the titre of the input phage 
was erroneously high.
■Eighty phage obtained from the above biopanning experiment were selected for further 
analysis (Table 2).
3.6.1 ELISA of phage selected in a third round of biopanning with anti- 
CPS antiserum and eluted with CPS
Phage from all 80 clones were bound to microtitre plates and tested by ELISA for their 
binding of biotinylated rabbit anti-CPS antiserum. Figure 23 shows the results for 
those phage which yielded absorbance values above the level of the background 
control, clone 78, a phage shown by sequencing to contain no insert and, therefore, 
one which should show no specific binding to the anti-CPS antibodies.
3.6.2 Estimation of concentration of phage by ELISA 
Determination of the concentration of fd-tet phage in a suspension is difficult (Smith,
1993) as the virus does not form clear plaques, and transformation of E. coli to yield 
tetracycline-resistant transformants occurs with variable, usually low, efficiency.
Therefore, quantification by ELISA, using an HRP-labelled anti-M13 antiserum, was
Figure 23. ELISA of 80 isolated phage selected hy 
biopanning a 6-mer library with anti-CPS antiserum.
The 1st round elution was with glycine/HCl and the 2nd and 3rd 
round with CPS (120 pg/400 ml). The background reading is 
shown by the dotted line. Only those phage with results higher than 
background are shown.
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Ïused to determine whether certain phage had been amplified adequately for the anti- %
CPS-binding ELISA. The results (Figure 24) show that the concentration of the 
purified phage varied widely with 20 of the phage tested giving absorbance values close 
to the background control level. Such phage probably require re-amplification to a ihigher concentration before reliance can be place on ELISA results to assess binding to 
anti-CPS antibodies. However an absorbance value significantly above background 7
(Figures 14 and 15) could be taken as evidence that that particular phage was capable of 
binding to anti-CPS antibody. A few of the phage whch gave positive results (shown 
in Figure 24) were tested at various dilutions for comparison with the 1 x IQl^
Îvirions/ml stock phage library (Figure 25).
%
Figure 24 . E L ISA  for detection of fd phage using anti- 
M IS antisemm. ELISA of 74 phage, selected by biopanning 
with biotinylated anti-CPS. Of the 96 phage obtained in 
biopanning with anti-CPS MAb, 74 were used to coat microtitre 
plate wells in an ELISA in which phage were detected with anti 
rabbit anti-phage-M13 antisemm and HRP-labelled goat anti-rabbit- 
IgG antisemm. (phage 21, 71, & 77 have been omitted)
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Figure 25. Effect of phage concentration in the phage anti- 
M13 antibody ELISA
The phage tested were numbers 16, 25, and 48 selected by biopanning 
with biotinylated anti-CPS antiserum, and the 6-mer phage library stock 
(1 X 10^5 virions/ml)
f
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3.7 Determination of DNA sequences of inserts in phage eluted with 
CPS in a third round of biopanning with anti-CPS antiserum
In Figure 26 the DNA sequences of inserts in 22 phage chosen for analysis are shown 
with the amino acid sequences encoded by the inserts. Three groups of identical 
sequences were found, each containing two members. The other sequences appear to 
have little in common, and there was no obvious relationship with the sequences 
determined for the earlier round of elution with CPS (Figure 20). Two sequences of 
particular interest were phage 15, containing a five amino acid insert, and phage 78, 
which contained no insert. The sequences of four clones were unreadable probably 
because the concentration of DNA was too low for sequencing.
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Figure 26. Amino acid sequences of inserts in proteins of phage selected 
from the 6-mer library in a third round of biopanning with anti-CPS 
antiserum
In the first round of biopanning phage were eluted with glycine/HCl and in the second 
and third rounds with CPS (See Figure 9).
Phage
number
Amino acid 
sequence genetic code
50 - TRP ARG ASN TRP ARG HIS (TGG A GG AAT T G G  C G T CAT)
71 - TRP ARG ASN TRP ARG HIS (TGG A GG AAT TG G  C G T CAT)
85 - TYR HIS PHE ALA ARG THR (TAT CAT T T T  G C T  C G T A CT)
90 - TYR HIS PHE ALA ARG THR (TAT CAT T T T  G C T  C G T A CT)
20 - PRO ARG LEU PRO PHE SER (CCT CG G  C TG  C C T T T T  TC G )
37 - PRO ARG LEU PRO PHE SER (CCT C G G  C TG  C C T T T T  TC G )
54 - PHE TYR SER ALA SER ISO (TTT TAT T C G  G C G  T C T  ATT)
59 - TYR HIS LEU SER LEU ASN (TAT CAT T T G  A G T CTG  AAT)
15 - PRO SER ILE SER GLN (5-MER) (CCG TC T  A TT TC G  CAG) 
88 - PRO GLY LEU PHE HIS TYR (CCG G G T C TG  T T T  CAT TAT)
10 - LYS PRO SER ARG THR VAL (AAG CCT A G T C G G  A CG  G TT)
67 - LYS PHE ALA LYS VAL ARG (AAG T T T  G C T AAG G TG  AGG)
4 - MET LYS GLY GLU ALA ASN (ATG AAG G G G  GA G  G C T AAT)
58 - MET MET SER LEU THR ARG (ATG ATG A G T T T G  ACG CG T)
25 - ILE GLY TYR LEU GLY GLY (ATT G G T TA T C T T  G G T CG G )
81 - VAL GLY ARG SER VAL LEU (G TT GGG CG G  T C G  G TT CTT)
87 - ALA GLY ARG TYR LEU HIS (G CT G GG CG G  TA T C TT CAT)
78 -WT (wild type, no insert)
IX  30X 35X 40X (unreadable)
;•tt'4:4
I
i
:s
I
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3.8.2 B iop an n in g  w ith  b io tin y la ted  a n ti LPS m onoclonal antibody
Three rounds of biopanning were executed as described in the Materials and Methods 
(section 2.4.11).
3.8.3 E L IS A  of phage  selected  by biopanning with anti-LPS M A b
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3.8 B iopann ing  o f th e  Sm ith  6 -m er phage lib ra ry  using  m onoclonal 
an tib o d y  to  A. salm onicida  LPS
One of the difficulties inherent in using a polyvalent antisemm is the variety of epitopes 
to which antibodies will be present and the difference in affinity of different antibodies 
directed against the same epitope. This can be eliminated by using monoclonal 
antibodies (MAb) as they are homogenous and it can be assumed that they bind to a 
single epitope.
3.8.1 B io tin y la tio n  o f an ti-L P S  m onoclonal an tib o d y  
The anti-LPS MAb 'F9 clone 16'was biotinylated and separated from unreacted biotin 
by gel filtration (Figure 27). Fractions 4 and 5 were pooled and contained 1.1 mg/ml 
protein, with a biotin/protein ratio of 6.
Phages recovered from the three rounds of biopanning with anti-LPS MAb were 
amplified and purified for ELISA, using method C (Section 2.6.4). The results are 
shown in Figure 28. The high background absorbance at 405nm of the control, almost 
0.6, is shown by the dotted line. Each of the three ELISA plates used for this 
experiment contained duplicate samples of LPS at three concentrations, the lowest of 
which, 0.1 p.g/ml LPS, resulted in a very low absorbance, although concentrations of 
10 and 33 p,g/ml LPS gave readily detectable responses. The results for the phage were 
all below that of the control value and the average values for groups of different origin 
are shown (see Figure 28), to simplify presentation. It would appear that no high 
affinity binding phage had been selected in the biopanning with anti- LPS antibody. 
Attempts to improve the ELISA were unsuccessful and it was decided to determine the
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Figure 27. Separation of biotinylated anti-LPS 
immunoglobulin from free biotin by Sephadex G 25 
chromatography.
One ml biotinylated immunoglobulin reaction mixture from rabbit 
antiserum to A. salmonicida CPS was applied to a column of Sephadex 
G25 Fractions of 1 ml were collected and the absorbance at 280nm 
measured. Fractions 4 and 5 were combined to give 4 ml of 
biotinylated antibody. Free biotin was eluted in subsequent fractions 
(not shown).
Figure 28. ELISA of 96 phage selected by biopanning 
with anti-LPS monoclonal antibody
This ELISA was earned out on three plates which each contained a 
set of LPS controls in which LPS was added instead of phage, in 
duplicate, at concentration of 0.1, 10 and 33 mg/ml.
TBS (instead of phage) control (background level) is indicated as a 
dotted line on the graph.
The phage results were averaged in group order as follows. 
1 St round
lA = Tube 1 / 1st wash (clones 2-6)
ID = Tube 2 / 2nd wash (clones 7-10)
2nd round
2A = Tube 1 / 1st wash (clones 11-15)
2D = Tube 2 / 2nd wash (clones 16-20)
3rd round
3A = Tube 1 / 1st wash (clones 21-51)
3B = Tube 1 / 2nd wash (clones 52-65)
3C = Tube 2 / 1st wash (clones 66-76)
3D = Tube 2 / 2nd wash (clones 77-96)
Chapter 3 Results 64
m
fO
O
O
00 \o o<3
□
and 87 are identical to, respectively, LPS clones 21, 75, 53, 71, 13, 42 and 65. 
The significance of this is discussed in more detail later.
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insert sequences of the phage to look for any bias of selection which might be detected 
by sequence similarities.
3.8.4 DNA sequence determination for 6-mer phages selected by 
biopanning with anti-LPS monoclonal antibody
The peptide inserts coded for by these phage are shown in Figure 29; 5 main sequence 
groups were found and the numbers of these phage have been listed along with their 
group sequence to simplify presentation. Against each sequence is shown a code to 
indicate its origin e.g A3 (see methods).
The genetic codes for the amino acid inserts are shown since identical amino acid 
inserts could arise from different DNA sequences It is of interest to note that identical 
phage had been selected in the parallel biopaning experiments in tubes A to D, e.g. 
phage 70 from C3 is identical to phage from A3. This is also shown for phage 80 from 
0 3  and phage 66 from C3, however, these clones did originate from the same product 
of the first round of biopanning. Phage 57 contained the wild type gene iii (see figure 
30) and phage 18 contained a 5 amino acid insert; the significance of which is discussed 
later.
Phage 80 which has the sequence ASN LEU MET ARG LEU TYR, can be compared 
to Phage 82 which has the sequence ILE SER ARG MET LEU PHE. The 3 amino 
acids underlined are reversed in the two clones as are the (TRP ARG HIS) sequences 
found in phage 47, reversed in phage 68.
Certain phage isolated during LPS biopanning had identical insert sequences to phage 
isolated during biopanning with anti-CPS antiserum, e.g. phage 18 from the second
i'l'
round of CPS biopanning has a sequence identical to that from anti-LPS biopanning 
(phage 79). From the 3rd round of anti-CPS biopanning phage 50, 90, 54, 15,4, 81
3
Chapter 3 Results 66
13<1
C
X )
£•u
e»«(Q
CL
S3
<u
Æ
•S
§CQ
§■
%
13
i
:a>>.a
1"oc^n
O)&J0J(3,
%
<yw
s
g.(W
o\ m
XIo.c
IX3
_cDh13
•E
•S
oc‘5Î)
o
&
00
I
Îobû
jC
'QoJ3
‘-M
§ %
I
1rO
'B§
11!<u <u W3 ^
i ' i
I
i5  gI t03 2
S13
Io
cuICJt/1I
s
Dwd-00
t>
S o s
3
\o
<
m
g;
Üo<:eH
H
S
g<
E—< W
I
%ort<
>^5
O o
^  z
K  g  
O
kJ
l g
H  ( N  
§
r rm.xQO 
M  ’' 3 “
8
<
Üo
H
o o
œ
g
<B
z
C O
<
ÜP<<B
P i
w
C O
O
Oh
u o
g I
<ri CO <  U
<
H
S
H
Ü
U
O
Ü
H
S
I-ooo^
l / T  T f00 OS
C O
Q
OS
o
Ü
H
U
H
S
H
U
U
o
< 3
H
g
Oy
s
£
gOh
@
C O
0
HI
XW
X C OléS&
m m  m  UPt  p q
So %
^ ^ 0 0  3
c nm
min
g
<
B
H
OUoou
H
g
d
g
C O
<
<
o g
w
C O  
f —<I
O
1 3
m
PQ
00
l o
U
00
\ o
O
O
c
H
g
O
o
H
Ü
Ü
<
H
<
U
o
H
H
I
o
Oh
g
Ü
0 4
m
a
u
H
H
3
H
H
C
O
u
o
o
o
H
<
u
m
G O
3
d<
ii
s
o
%§ >£
Chapter 3
bû
<U QJ
8
s
&si1
I
I
s
OUo
g
E
Results
Q U
o so
O
3
Ou
H
H
O
H O Ü O H U
g j
ÇQ m
Q  ■ PQ
fO o  OS so
g I  
i  gO H <H
3
HOu
E
m
PQ
tH  C4
g B I S 
s i
Ü o  H O O U
8  8H Ü
V©€4 e4
O Os  sse
o  o u  uÜ o
O  Os fO UP
m ro 
PQ PQ
iri mIf) so
OOO
Ou
HoHH
O U
o
Ü
H H O < O uH H
8  BHS
HUC
HUH
8
OUH
E
oHU
H
I
g  8
OoH -4 O OH H O U O O
If)
67
u u 0 < <
fO!> v™( i f ) Tf
o H
O'
O
o U Ü OH < <! UO H o H oo O < U u< u U H uH H O O ÜU u u uÜ o H u uo PMH ou H E=h o uH H < < o
O H H H< U p <O U H H H
O H o Ü< ■4 U o HÜ H U o O
C4
H
8UH
UH
:'V%
f
3
IW)I
j
M W
K CO
. to ^ 5PhCO O
s  %
y B 8  s
a  a
B i l
ff i COP
H Ü
a  g;
S i si l l
O  >  CO
Chapter 3 Results 68
O)U)C3
OÎssè)
a
bjo
1ed
§■
©
13ItM©gJS
13II
So
Pm
©©
g
ta
X)I
§
aI
I>'B
<D•s
' â
.2o
§)
gCO
I s
IJO
1©<o
13©I ^I I 1
ou
I
&
1&k,a
XÎI
g
©
8
I
I
S
S'
I
n
©3I
1C3I<
g
3to
s
SO’©
"C©
©i3O’©
a
fO r«l OS
8  o
\o l>
Q Q
O 00 M T-4
o o
o  o
CO CO
B l
Ü P
O P sa  (P pd CL o
if)
Ê p
o H
H H
o c^«
c -
(>•
O'
3 3
g
k-J
I
O' O'
O' O'
O' O'
i O' O’
TTIf) m
Chapter 3 Results 69
S ’ l/^SâKT
INSERT
Figure 30. Autoradiograph showing the DNA sequences of phage 56 
and 57. Phage 56 displays a 6 amino acid insert whereas phage 57 
contains no insert. Both phage were selected from the last of three rounds of 
biopanning the 6-mer phage and anti-LPS MAb.
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3.9 Biopanning of a 15-mer phage-displayed peptide library with 
biotinylated anti-LPS monoclonal antibody
'..:4The 15-mer phage library was treated in the same as the 6-mer library and three rounds
■
of biopanning were completed (see methods).
3.9.1 ELISA of 15-mer phage selected using anti LPS monoclonal 
antibody
The ELISA results for the 45 phage are shown in Figure 3 1 with the background 
absorbance obtained using stock library phage shown by the dotted line. The 
absorbance values were similar to that of the control line. The LPS controls gave 
absorbance values only marginally above background which may have been due to 
poor binding of the LPS to the plate.
3.9.2 DNA sequences of the inserts in phage from the 15-mer library 
selected using biotinylated anti-LPS monoclonal antibody
Surprisingly, none of the sequences determined revealed 15 amino acid inserts (figure 
32), there being 2 phage with six amino acid inserts and three with wild type gene III 
sequence (no insert).
Figure 31 . ELISA of 45 phage selected by biopanning
a 15-mer library with anti-LPS monoclonal antibody
The microtitre plate was coated with purified phage (in duplicate 
wells) and subsequently treated with biotinylated anti-LPS 
monoclonal antibody. Development was with HPR avidin and 
ABTS. Phage used were selected from the 15-mer library with 
biotinylated anti-LPS monoclonal antibody.
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A m ino acid 
sequence genetic code
3 7  HIS VAL ALA ILE HIS SER (CAT CTG GCG ATT CAT TCG)
4 0 HIS VAL ALA ILE HIS SER (CAT CTG GCG ATT CAT TCG)
36 W T (wild type)
38 W T
39 W T
"P
p
F ig u re  32. A m ino acid  sequences o f in se rts  in  phage  selected  by 
b io p an n in g  a 15-mer phage lib ra ry  w ith  b io tiny la ted  an ti-L P S  
monoclonal antibody
The 5 phage sequences were derived from phage recovered from tube 12 (see 
figure 11). The first round phage were recovered by elution of bound phage with 
glycine/HCl bufferr and then by LPS in the subsequent two rounds.(see Figure 
11 for full description).
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3,10 E lec tro n  M icroscopy o f uninfected and phage-infected cells
s-Because wild-type phage sequences were found on a small number of occasions 
(Figures 26, 29 and 32) it was decided to investigate whether wild-type phage might be 
present in stocks of uninfected E. coli K91kan cells, and also to determine whether it 
might be feasible to obtain direct counts of phage preparations. When uninfected cells 
were viewed with the electron microscope no bacteriophage could be seen, compared 
with infected E. coli K91kan cells which contained readily visible numbers of phage 
(Figure 33).
Figure 33 shows an electron micrograph of two isolated phage lying parallel to each 
other. Although the staining was slightly uneven the entire length of the phage can be 
seen.
Figure 34 shows a single filamentous bacteriophage associated with an E. coli cell. It
■
is possible that the proximal end of the phage is attached to the underside of the cell.
It was not considered feasible to obtain total virion counts on a regular basis for large 
numbers of phage solutions generated in biopanning.
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Figure 33. Filamentous bacteriophage viewed by Transmission electron 
microscopy photograph.
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Figure 34. Transmission electron microsgraph of a phage infected E. 
coli  cell.
4. DISCUSSION
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of such an organism, this could not be readily applied to polysaccharide antigens. 
Thus, the possibility that polysaccharide epitopes could be mimicked by peptides is
Successful vaccines have now been produced commercially against several fish 
pathogens, such as Vibrio anguillarum, Yersinia ruckeri and A. salmonicida. In the 
vaccines against V. anguillarum  and Y. ruckeri the protective antigens are considered 
to be LPS (Ward et aL, 1985; Ellis, 1988; Smith, 1988), and protection is serotype- 
specific. In contrast, in furunculosis the LPS does not seem to be important in 
generating a protective immune response. According to the work of Hirst and Ellis 
(1994) the antibody response directed against iron-regulated outer membrane 
proteins is correlated with protection, although a second antigen which enhances 
protection when incorporated into vaccines is "soluble lipopolysaccharide" (Bricknell 
et al., 1997), a compound probably synonymous with CPS, given the similarities in 
properties (Garrote eta l., 1992; Garduno and Kay, 1995).
Although crude LPS for use in vaccines can be prepared quite simply from most 
organisms by heating the bacterial cells at 100°C (Campbell, 1964 In; Methods in 
immunology), thus denaturing protein antigens, other organisms may be more 
difficult to culture in quantities required for large-scale use in vaccines. An example 
of this is the intracellular bacterium Piscirickettsia salmonis, which must be grown in 
vivo or in tissue culture cells (Fryer et al., 1990). Although a molecular biological 
approach is feasible for expression of protein antigens, e.g. outer membrane proteins.
worthy of investigation, and for this purpose the A. salmonicida antigens LPS and 
CPS were chosen as model systems. When this work began, it had been reported that
phage display libraries had been used to identify peptides mimicking sugars or 
oligosaccharides such as a-D-methylmannoside (the ligand recognised by
,
concanavalin A; Oldenburg et al., 1992; Scott et al., 1992), the LewisY blood group
:antigen (Hoess et al., 1993), and the receptor for the cell adhesion molecule, E- 
selection (Martens a/., 1995).
-
The interaction between the binding site of an immunoglobulin molecule (or 
paratope) and an epitope of an antigen arises from complementarity in shape, charge
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distribution and the opportunity for hydrogen bonding to occur (Eisen 1990 In: 
Microbiology 4th ed.). It has been predicted by Barlow (1986) from consideration of 
the surface properties of proteins that most epitopes on proteins will be discontinuous, 
i.e. comprised of amino acids adjacent to each other in the tertiary structure but not in 
the primary amino acid sequence. The production of mimotopes, linear peptides 
which mimic the discontinuous epitope (Geysen etal., 1986), and internal image 
monoclonal antibodies, capable of mimicking an epitope recognised by a monoclonal 
antibody (Poskitt eta l., 1991) suggests that a search for peptides which mimic 
polysaccharide epitopes may be worthwhile.
Two different strategies were adopted in this work, the first using a polyvalent 
antiserum to A. salmonicida CPS, in which it was decided to elute bound phage by 
displacing it with the native antigen, CPS. This procedure ought to displace only 
those phage binding to the anti-CPS binding sites, and in successive rounds select 
phage of higher affinity. The second approach was the conventional method of using 
a monoclonal antibody, in this case to A. salmonicida LPS, in which all bound ligands 
in the biopanning process would be identical.
4.1 Selection of phage binding to anti-CPS by biopanning from a 6-mer phage 
display peptide library
In the two biopanning experiments summarised in Table 2 (p.42), the percentage 
recovery of phage was low and did not increase during the three rounds of 
biopanning. However, the ability of phage to bind to anti-CPS antibody was screened 
to identify which might have an affinity for antibody.
It was initially considered that those phage which gave absorbance values above 
background level had a moderate to high affinity towards the anti-CPS antibodies, 
and those with low, or background, absorbance had a low affinity. However, the low 
absorbances may have arisen because the concentration of certain amplified phage
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was too low to produce sufficient binding sites for the anti-CPS antibodies. When the 
effect of concentration of phage on the ELISA absorbance was tested with 'high 
affinity' phage, Figure 17 showed that a dilution of 1/10 and 1/32 was sufficient to 
reduce the absorbance of the 'high affinity' phage from clones 1 and 2, respectively, 
to background level and equal to that of the low binding phage from clone 6. From 
these results it was concluded that the phage which yielded absorbances above 
background level were present in adequate concentration and displayed an affinity for 
the anti-CPS antibody. However, those phage giving an absorbance at or below 
background may either be those with a low affinity, or phage with a high affinity 
which had not been amplified to a sufficiently high concentration to be detected by 
the ELISA method. As previously noted, this would only require the reduction of 
amplification of phage by one tenth that of the high affinity clone 1.
I
The consistency of the ELISA method was demonstrated by the results shown in 
Figure 16, when comparing six repeat samples for each phage. These results were 
consistent within the experiment and were comparable with the initial ELISA results 
(Figure 15) for the clones tested. Further evidence that the amplification process led 
to widely differing yields of phage was obtained when ELISA was used with anti- 
M l3 antiserum to detect the phage amplified after selection with MAb to LPS (Figure 
24).
To determine whether there was indeed any affinity of the selected phage towards the 
antigen binding site of the antibody it was decided to carry out a competitive ELISA.
The first point to be revealed from the results in Figure 18 was that phage 6, which 
was initially deemed a low affinity clone, is in fact a high affinity clone when assayed 
with the re-amplified phage 6 stock used for this experiment. The results of the
'competitive ELISA were inconclusive in that there was no clear dose-dependent 
inhibition by CPS of the binding between phage and antibody. Although the low 
concentrations of CPS inhibited binding of phage to antibody the high concentrations 
were not inhibitory. In all cases, concentrations of 1 fig/ml or 0.32 pg/ml CPS
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inhibited the quantity of phage bound (Figure 16). It is possible that the ratios of 
CPS, antibody and phage favoured the formation of mixed complexes, comprised of 
phage and antibody interacting with CPS. Nevertheless, the high absorbances 
obtained with control phage in the absence of CPS provide further evidence that the 
phage have an affinity for the anti-CPS antibodies. The poor ELISA signal when 
CPS was bound to the plates as a positive control to detect anti-CPS binding was 
attributed to the well-recognised difficulty in obtaining good binding of 
polysaccharide antigens to microtitre plates under conditions normally used for 
binding protein antigens (Bantroch cf (3/., 1994). Preliminary experiments were done 
to verify the best conditions for binding CPS using various concentrations of CPS and 
various pH (Figure 19). For concentrations of 20-160 p,g/ml CPS the best pH for 
binding was pH 9 with the amount of CPS bound being concentration dependent. 
However, further work on the ELISA methodology was discontinued as it was 
considered more profitable, in the limited time available, to determine the DNA and 
hence peptide sequences of the inserts. This involved the sequencing of a section of 
the phage DNA containing the eighteen-base-variable oligonucleotide.
For sequence determination, phage which appeared to have a high affinity for the 
anti-CPS antibody were chosen, along with a selection of 'low affinity' phage.
Of the seventeen phage for which the insert sequences were determined it was 
interesting to note that ten of these contained inserts with a GLY SER GLY motif in 
the first three amino acids. Equally important, the subsequent three amino acids of 
the GLY SER GLY' group of phage were of variable sequence. This suggests that 
these phage were selected for because of their GLY SER GLY' motif rather than, for 
example, if their genetic coding sequences had been identical and the phage had been 
present in a large copy number in the library. In the latter case the phage could have
" i:.
Î
passed through the biopanning process purely because of their quantity rather than 
because of selection.
IrI
: i
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Partial similarities, such as those obtained, suggest that the serine and glycine 
residues in the GLY SER GLY format are being selected for. The serine residue 
contains an hydroxyl group which may be recognized by the anti-CPS antibody since 
each of the sugar units found in the CPS also contain hydroxyl groups (Appendix 3).
If this is the case, the occurrence of other hydroxyl containing amino acids, threonine 
and tyrosine, might also be expected. Threonine does indeed appear in sequence 1 
(Figure 20) as part of the motif 'GLY THR GLY SER' which is very similar to the 
insert sequence of phage 4 , 'GLY SER GLY SER'. These motifs may mimic CPS to 
a greater extent than those containing only one hydroxyl side chain since alternate 
hydroxyl-containing amino acids may mimic the hydroxyl groups and their spacing 
on the various sugars in CPS. Phage 18 insert, which contains the m otif PRO TYR 
SER PRO’ is interesting in that not only does it contain the hydroxyl carrying amino 
acids TYR and SER but these are flanked by the 'kink forming' amino acid proline 
which may cause the TYR SER residues to protrude from the surface of the PHI 
protein on which it is displayed, perhaps making these hydroxyl-carrying amino acids 
more accessible to the anti-CPS antibody.
As previously noted, all clones sequenced from this round of biopanning contained 
the amino acid serine, including the four clones assessed by ELISA as being of low 
binding affinity. As discussed previously, these phage may have been erroneously 
labelled as having low binding affinity because they were not amplified to sufficiently 
high concentration for the ELISA. This is especially relevant for phage 14 and 20 
which contain the distinctive motif GLY SER GLY'. Since these clones are identical, 
it is possible that the insert may have had greater effect on the infectivity of the phage 
than other insert sequences, i.e. the insert may have disrupted the function of the PHI 
protein and thus reduced infectivity, which would in turn reduce the yield of the 
phage on amplification.
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A further unexpected finding was that one of the sequences contained only two amino 
acids (Figure 22); however, the sequence determined, 'GLY SER', was very similar 
to the common motif GLY SER GLY' noted above. The GLY SER' motif, although 
apparently shorter than the 'GLY SER GLY’ motif discussed above, is actually 
expressed as 'GLY SER GLY' because glycine is the first amino acid expressed in 
the non-variable section of the PHI protein. The unusual occurrence of a two amino 
acid insert is discussed later but its selection here was further confirmation of the 
power of the biopanning process.
After re-amplification of the second round eluate from the CPS biopanning and 
continuing to a third round, the phage selected from this round were again assayed by 
ELISA. Few clones gave significant positive results (Figure 23) and for this reason a 
semi-quantitative assay for phage concentration was developed using an anti-phage 
M13 antibody ELISA (Figure 24). With this technique it was possible to determine 
whether particular phage had been amplified to a detectable concentration, and 
showed that approximately one third of the clones required further amplification.
Analysis of the sequences, yielded the surprising result that the previously determined 
motif GLY SER GLY' was not found. The reason for this is unclear. However, 
variations of the motif, with the amino acids replaced by those with similar functional 
groups, did occur. This can be seen in that many of the inserts contained an 
hydroxyl- carrying amino acid, flanked by various members of the aliphatic amino 
acid group. Examples are phage 59 and 25 with the motifs 'LEU SER LEU' and 
GLY TYR LEU', respectively.
Further examination shows that of the 17 sequences which could be read, 13 
contained hydroxyl carrying amino acids; of these, 7 contain more than one hydroxyl- 
carrying amino acid. Clone 54 is of particular interest since it contains 3 hydroxyl- 
carrying amino acids, viz. PHE TYR SER ALA SER ILE', which again shows a 
serine flanked by aliphatic amino acids (ALA and ILE). Again, it may be that the
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hydroxyl groups which are carried by the serine and tyrosine amino acids are 
recognized by the anti-CPS antibodies.
As found in the previous experiment a non 6-mer phage was detected, however, this 
phage displayed a 5 amino acid insert rather than a two amino acid insert. It may be 
that these unusual phage occur with a high frequency in the library and hence appear 
at an equivalent frequency after biopanning. However, since both the 2-mer and 5- 
mer contained the amino acid serine, it is suggested that they are selected for to a high 
frequency via the biopanning process. The occurrence of non 6-mer phage and wild 
type phage (clone 78) are discussed later.
W ork by Hoess et al. (1993) deduced that the consensus amino acid sequence
APW LYGPA was selected by a monoclonal antibody (B3) raised against a
carbohydrate antigen. It is interesting to note the similarity between the LYG (LYS
TYR GLY) moiety in this sequence with the 'GLY SER GLY' moiety, and similar
.combinations, of hydroxyl-carrying amino acids flanked by two aliphatic amino acids 
obtained in the previously discussed experiments with anti-CPS antibody. Since the 
anti-carbohydrate antibody recognises the sugar units of the carbohydrate it is not 
surprising that similarities occur between the phage obtained using anti-CPS and 
those using other anti-carbohydrate antibodies. It would, however, be interesting to 
test the extent of cross reactivity between these antibodies against both sets of phage.
4.2 B iopanning a 6-mer phage lib ra ry  w ith a m onoclonal antibody to LPS 
After the three rounds of biopanning with the 6-mer phage library and monoclonal 
anti-LPS antibody, selected phage were assayed with ELISA, but there was no 
indication (Figure 28) that any selection has occurred. However, it should be noted 
that the LPS control concentrations of 10 & 33 pg/ml did not give absorbance values 
as high as in previous experiments, indicating a possible problem with at least one of 
the many ELISA steps or components. Despite carrying out various tests to improve
■
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the ELISA system, it was deemed more productive to carry out sequence 
determination for inserts of the selected phage than to pursue the problem further.
The most obvious findings from the phage sequences were the oceurrence of groups 
of up to eleven phage with identical sequences and that, secondly, of the 70 readable 
sequences, 52 contained hydroxyl side-chain carrying amino-acids. The most 
common sequence was 'ASN LEU MET ARG LEU TYR' which not only appeared 
eleven times but was also isolated from each of the four separate tubes (A, B, C and 
D) during biopanning.
W hen compared with the finding for CPS biopanning, the phage selected during 
biopanning with anti-LPS had similar motifs, i.e. with hydroxyl-carrying amino 
acids flanked by aliphatic amino acids, typified by the sequence 'ALA SER ILE' in 
phage 53 and 'VAL TYR ALA' in clone 4. Additionally, sequences such as LEU
MET ARG' found in phage 80 are found in reverse in phage 82; similarly, the
■
sequence "TRP ARG HIS' found in phage 47 is found in reverse in phage 68. Phage 
47, and those phage isolated with the same sequence, are of interest since they appear 
to have been selected yet contain no hydroxyl-carrying amino acids. This same 
observation can be applied to phage 68 and 58 which have the same sequence yet 
have different tubes of origin. As mentioned previously, there is a common motif
'between these phage, the sequence TRP ARG HIS'. Also, two amino acids distant 
.from the TRP in either direction, the amino acid ARG occurs. This suggests that 
these amino acids may also be recognized by the anti-LPS antibody. Further tests 
with ELISA require to be carried out to verify whether these phage have an affinity 
for the anti-LPS antibody. This experiment, as with the CPS biopanning experiment, 
yielded some unexpected sequences. Phage 57 carried the wild type Gene III 
sequence and phage 18 contained a five amino acid insert.
4.3 Identical phage sequences selected during anti-CPS biopanning and anti- 
LPS biopanning.
■À
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The occurrence of identical phage sequences obtained from anti-CPS biopanning with 
those obtained with anti-LPS biopanning, as noted above, could be due either to an 
excess representation of these phage in the 6-mer stock library, causing them to pass 
through the biopanning system via quantity rather than via selection or, it could be 
due to recognition of similar epitopes by the anti-CPS and anti-LPS antibodies. The 
composition of LPS and CPS is very similar (Appendix 3.), but further experiments 
are required to test the degree of cross-reactivity between the sequences obtained and 
the anti-CPS and anti-LPS antibodies. The possibility that a common sequence on the 
rabbit and mouse immunoglobulin is recognised, cannot yet be discounted.
4.4 Biopanning with a 15-mer phage library and anti-LPS antibody
As noted earlier (results section 3.8.3), the phage selected from the 15-mer library 
gave ELISA results (Figure 28) similar to the control background level but, 
nevertheless, it was decided to sequence a small number of the phage selected. The 
inability to detect 15-mer insert sequences was surprising, but as the two insert 
sequences were identical to those of phage 22 and 32 from the anti-LPS 6-mer 
biopanning experiments, the possibility of cross-contamination cannot be ruled out. 
However, the frequency with which wild-type sequences, i.e. no insert, were formed, 
was much higher than with the 6-mer library (3/5 compared with 1/50 for the 6-mer 
library) which indicates that the origin of the 15-mer library is most unlikely to be the 
6-mer library used in the study,
4.5 Occurrence of wiid type phage and non-6-mer sequences
The occurrence of the wild type Gene III sequence, although unexpected, was not 
unusual as it is well recognised that this can occur in construction of libraries. The 
electron microscopy discounted the possibility that the host E. coli K91 Kan carried 
the wild type fd phage (containing no antibiotic resistance) since no phage were 
detected in non-infected cells whereas they were readily seen in infected cells.
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As stated by Bonny castle et al. (1996), the quality of a phage library can be assessed 
in terms of several parameters. These include the number of clones in the library, the 
level of peptide expression on the virion and the errors in the DNA sequences 
encoding the peptide inserts. In the 11 phage libraries characterised by Bonny castle 
et al. (1996) the occurrence of wild type sequences varied from 0% to as much as 
19%, and the occurrence of unexpected or 'deviant' insert sizes ranged from 0% to 
17.6%.
Thus the finding of a low frequency of wild-type and deviant sequences in the 6-mer 
library (2% and 3% respectively), suggest that it was satisfactory in this respect. For 
comparison, the 6-mer library of Bonnycastle et al, (1996), contained 7% wild-type 
sequences and 0% deviant sequences.
4.6 Selection of phage sequences which do not mimic an antigenic determinant 
ofLPS or CPS.
The assumption implicit in the discussion so far is that the sequences selected have 
been related to the structure of LPS or CPS since they were selected by the anti-LPS 
or anti-CPS antibodies. However, it is possible that the phage may have been 
selected because of their reactivity against streptavidin, biotin or even the plastic of 
the tubes. Selection of phage against streptavidin or plastic is unlikely since biotin or 
plastic surfaces, if not bound by antibody, should have been blocked before the phage 
was added. However, the biotin molecule may be exposed since each antibody 
molecule has, on average, several covalently-bound biotin molecules, and not all 
would be used to bind to the streptavidin. Robert et al. (1993) determined a 
consensus sequence of 'X X TYR TYR LEU HIS' for phage isolated using anti-biotin 
antibody. This sequence is reminiscent of many of those obtained using selection 
with anti-LPS antibodies since the motif of 'LEU TYR' occurs in many of these 
sequences. However, the greatest similarity to this 4 amino- acid consensus is that of
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phage 87 from anti-LPS biopanning which has the 3 amino acid sequence of TYR 
LEU HIS. The sequence for phage 87 suggests that this phage may perhaps have 
greater affinity towards biotin than to anti-CPS antibody. Closer inspection of the 
sequences obtained by other workers (Robert et al., 1993) for anti-biotin or 
streptavidin biopanning shows that none of the sequences obtained contained the 
amino acids serine or threonine. This suggests that the phage selected here which 
contain these amino acids are less likely to have been selected because of an affinity 
to biotin or streptavidin.
4.7 Implications of more recent research
During the writing of this thesis other work has been published which is relevant to 
this project. Bonnycastle et a l . (1996) showed that they also experienced a certain 
occurrence of wild type phage and expressed concerns about the quality of the 
synthetic oligonucleotide used, and mention "toxicity" of certain peptide inserts. 
Interestingly, as deduced in this project, they note that certain phage varied in their 
amplification in E. coll by tenfold or greater. Bonnycastle attempted to obtain 
mimotopes to polysaccharide antigens using monoclonal antibodies D l, D2 and D3, 
respectively specific for Salmonella paratyphi (branched trisaccharide of the O- 
antigen of the LPS), Shigella flexneri (tetrasaccharide of the O-antigen of the LPS) 
and Streptococcus pyogenes (branched trisaccharide of the cell-wall polysaccharide).
The consensus sequences deduced from phage selected were: for D 1, the sequences 
YPM and TYVLTC ; for D2, CXNM, and for 03 CXLY and CXXLY. Cross 
reactivity occurred between these peptides and the anti-carbohydrate antibodies. It 
should be noted that there are similarities between the above peptides and those 
obtained within this study, especially the occurrence of the LY motif obtained using 
anti-CPS and anti-LPS antibodies.
More important advances were made by Phalipon et al. (1997) who obtained two 
immunogenic peptide sequences which were shown to mimic the O-antigen of 
Shigella flexneri. The phage selected using monoclonal antibody to the LPS
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contained several sequences including YKPLGALTH and KVPPWARTA.
Similarities between these peptides and those shown within this thesis can be 
observed with respect to the hydroxyl-carrying amino acids. The most important 
finding of Phalipon et al. was that phage displaying the above peptides could induce 
an immune response in mice, the antibodies cross-reacting with the O-antigen of 
Shigella flexneri. This is the first reported example of immunogenic mimicry of 
carbohydrate by phage-displayed peptides. Although the above peptides which 
mimic polysaccharides appear to be specific, Bonnycastle et al. (1996) suggest that in 
their work, due to similarities in saccharide structure, the phage isolated are cross­
reactive with other anti-saccharide antibodies. In contrast to this, Harris et al. (1997) 
showed that peptides selected by different anti-saccharide antibodies remained 
specific to the antibody which selected them. It should be noted that Bonnycastle et 
al. (1996) have not reported any results of immunisation with the phage-displayed 
peptides.
A separate approach to produce an effective vaccine using LPS may lie in
V-.
understanding and utilising internal image anti-idiotype vaccines. As described in the 
reviews by Poskitt et al. (1991) and Dalgliesh and Kennedy (1988), antibodies raised 
against a monoclonal antibody may bear an internal image of the antigen to which the 
monoclonal was raised, in accordance with Jerne's Network Theory (Jerne, 1974).
This antibody is known as the Ab2p anti-idiotype and may be used to induce an 
immune response. This system is thought to play a role in the transfer of immunity 
from mother to foetus. This is important since neonates up to 2 years have poor 
immunogenicity against polysaccharide antigens and would therefore benefit from 
passive immunisation to polysaccharides by polysaccharide-mimicking antibodies.
Mimicry of polysaccharide antigens by anti-idiotypic antibodies has been studied by 
Field and Morrison (1994), who demonstrated that an anti-idiotypic antibody which 
mimicked the inner core of Salmonella minnesota LPS, protected mice from a 
normally lethal challenge with LPS. Many other examples exist in the literature.
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4.8 Further work arising from this thesis
Only a very limited time was available to complete the work described in this thesis 
and it is recognised that a more thorough characterisation of the affinity of binding of 
phage to the antibodies is required.
Secondly, the sequences which either showed a good response with ELISA or have 
interesting amino acid sequences, should be tested for their ability to induce an 
immune response in fish and in mice. Serum samples could subsequently be 
collected and tested for anti-CPS and anti-LPS antibody production.
One major difference between this study and those of Bonnycastle et aL (1996) and 
Phalipon et al. (1997) is that these workers concentrated on phage libraries with 
peptides displayed in the virion major coat protein (pVIII). This has the significant 
advantage of displaying several hundred copies of the peptide insert rather than the 
two or three copies per virion displayed in pIII libraries. However, it is considered 
that sufficient progress has been achieved so far in this study to warrant further 
experiments, perhaps with pVIII libraries.
This research would suggest that production of anti-idiotypic antibodies against 
polysaccharide-mimicking peptides selected from bacteriophage-displayed peptide 
libraries may lead to an effective means of inducing an immune response in salmonid 
fish to the pathogen Aeromonas salmonicida.
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Appendix 1
Reagents used in biopanning 
E lu tio n  buffer
0.1 N HCl. pH adjusted to 2.2 with glycine 
1 mg/iTil BSA
0.1 mg/ml phenol red (optional)
The glycine/HCl buffer is made and adjusted as a 4x stock, filter sterilised, and 
stored at room temperature.
P hage s to rage  b u ffe r  (if needed)
0.01 M Tris base 
0.01 M gC h 6H2O
P o tassiu m  phosphate b u ffe r
0.17 M KH2PO4 (anhydrous)
0.72 M K2HPO4 (anhydrous)
Tris buffered saline
Î
50mM Tris/HCl pH7.5 
150mM NaCl
TBS/Tween solution
200 vol TBS
1 vol Tween 20 (final conc. 0.5% v/v)
Bacteria, culture media 
E. coU K 91kan
A "mini-lean hopper" was inserted into the lacz gene of K91 Escherichia coli 
with the aid of the catalyst vector IN K I105 consequently introducing
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kanamycin resistance to this organism (Way et a l, 1984). The strain was 
obtained from Dr. G. Smith (ref: SE94)
L n ria  ag a r
15 g/1 agar (technical no.3)
10 g/1 bacto-tryptone 
10 g/1 NaCl 
5 g/1 yeast extract
Lnria broth
10 g/1 Bacto-tryptone 
10 g/1 NaCl 
5 g/1 yeast extract
T e rrif ic  broth
To 900 ml water add 
12 g bacto-tryptone 
24 g yeast extract
4 ml (5.04 g) glycerol
Autoclave 90 ml portions and to each add 10 ml autoclaved potassium 
phosphate buffer
Kanamycin
100 mg/ml stock
T e tra c y c lin e  (h y d ro ch lo rid e )
40 mg/ml and 10 mg/ml stock solution (dilute was H2O rather than Ethanol)
C) A dd itional reagents for E L ISA
B lock ing  so lu tio n
0.1 M N aHCO s
5 mg/ml dialysed BSA 
0.1 pg/ml streptavidin
0 .02%  NaNs (optional) (store at 4 «C)
" 1
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S eq u encing  procedure
The S e q u e n a s e T M  version 2.0 DNA sequencing kit. (Product No, us 7077) was used. 
Step 1
For sequencing of single stranded DNA the annealing mixture consists of 7 pi DNA 
(prepared from bacteriophage as described above), 2 pi reaction buffer and 1 pi primer 
(0.5 pM). The mixture was heated at 65°C for 2 min, then cooled to 35°C over a 15-30 
min period before being chilled on ice until it was used in step 5.
Step 2
Eppendorf tubes labelled G, A, T and C each received 2.5 pi of termination mixture 
(dGTP).
Step 3
The labelling mix was diluted 5 fold (2 pi plus 8 pi H2O).
Step 4
The Eppendorf tubes labelled G, A, T & C were then placed in a 31°C bath.
Step 5
The labelling reaction was prepared as follows;
Ice chilled annealed DNA mixture from step 1 10 pi
Dithiothreitol, O.IM 1 pi
Diluted labelling luix 2 pi
RedivueTM [35s] dATP 0. 5 pi
Sequenase polymerase (diluted 8-fold) 8 pi
The components were mixed and incubated at room temperature for 2-5 min.
Step 6
Termination reactions.
Aliquots of 3.5 pi of labelling reaction were transferred to each termination tube (G, A, 
T, C). The tubes were then mixed and allowed to incubate at 37"C for 5 min.
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Step?
The reactions were stopped after 5 min by the addition of 4 pi of stopping solution.
Step 8
The samples were heated to 75“C for 2 min prior to mnning the sequencing gel.
P re p a ra tio n  and ru n n in g  o f po lyacry lam ide sequencing  gels 
The major components are "Easy gel" the ready prepared reagent Acrylamide/Bis- 
acrylamide 6% sequencing gel (ratio 19-1 7M Urea 1 x TBE) supplied by Scotlab 
(Product No. SL-9238), Temed (N,N,N,N-Tetra-methylethylenediamine) from Sigma 
(Product NO-T8133) and Ammonium persulphate in the following amounts
Easy gel 70 ml 
Temed 70 pi
Ammonium persulphate 140 pi (0.125 g/500 pi H2O) prepared directly before 
use)
The Gel plates were 42 x 33 cm and were mounted in a Model S2 sequencing apparatus 
from Life technologies Ltd with power supplied by a Gibco BRL electrophoresis power 
supply (model No. 2500).
The mixture was poured immediately into previously taped glass plates, the small plate 
being pre-treated with 'gel slick^^M' (A non toxic glass plate coating from AT Biochem, 
catalogue No. 219). The comb was inserted approximately 1 cm into the gel with the 
points facing outwards. The gels set after 1.5 h at which time the comb was reversed 
and inserted so that the points of the comb pierced the gel by approximately 1 to 2 mm. 
The gel was then loaded into the apparatus and the top and bottom reservoirs filled with 
TBE buffer. A syringe with a needle was used to wash TBE buffer over the wells to 
displace any residual urea that would interfere with loading the samples.
Aliquots of 3.5 pi of each sample were loaded in the order T, C , G and A. The gel was 
then run for 2.5 -3 h at 300 mA / 80 W  or 280 mA / 70 W. To facilitate reading the 
sequence of the gel it was found best to allow the fragments containing the sequence of
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interest to run to the end of the gel. A good indication of when this was achieved was 
when the first of the two dyes in the stop solution had just run of the end of the gel, 
which normally took 2.5 -3 h.
The smaller plate was removed and the gel was transferred from the larger plate by 
placing a sheet of filter paper on top of the gel and lifting it away, leaving the gel stuck 
to the paper in its original orientation. The gel was vacuum dried at 60°C for at least 3 
h. To determine the appropriate exposure time required for the film, the radioactivity of 
the dried gel was tested using a Geiger counter. In general, when counts (Using a mini­
monitor g.m.meter type 5.1.0 from Mini Instruments) of 50/sec and above were 
obtained, the film was exposed to the gel for 12 - 24 h; however, when lower counts 
were obtained the gels were placed against film for as long as 14 days to produce bands 
which were dark enough to read. Following development the sequence of the gel was 
deteimined. For the 6-mer libraiy, reading of an 18 base pair (bp) sequence was 
required, and for the 15-mer library a 45 bp sequence encoded the peptide sequence. 
These sequences were located by looking for the distinctive pre-sequence and post­
sequence patterns, TGCCCCGA and CCCCGGCGACCCCGG respectively. The 
'insert' sequence was easily identified by locating the three groups of four cytosine 
residues, from which the insert sequence was read directly from the film and a 
complementary strand constructed. The three bases immediately upstream from the 
insert G-C-T formed an alanine codon; this amino acid was be used to translate the 
reconstmcted sense-strand through the insert and into the region coding for pIII.
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Appendix 3 - COMPOSITION OF LIPOPOLYSACCHARIDE AND CAPSULAR POLYSACCHARIDE
LPS Molar ratios
Glucose, 1 .3 5
rhamnose, 1
N-acetylmannosamine, 1
(Partially acetylated, estimated from Fig. 1)
CPS
Glucose, 5
mannose, 3
rhamnose, 0 . 7 5
N-acetylmannosamine 2
mannuronic acid 1
from Shaw et a l, (1983) and Garrote et a i, (1992)
- î
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Appendix 4 - Bacteriophage fd  sequence (from E M B L  data base) accession no V00602
GENE V I I  = "MEQVADFDTIYQAMIQISWLCFALGIIAGGQR"
( 1 7 3 5  TO 1 8 3 6 )
GENE IX ="MSVLVYSFASFVLGWCLRSGITYFTRLMETSS"
(1833 TO 1931)
GENE V I I I =  "MKKSLVLKASVAVATLVPMLSFAAEGDDPAKAAFDSLQASATEYIG 
(1928 TO 2149)YAWAMVWIVGATIGIKLFKKFTSKAS "
GENE 1 1 1 =  "MKKLLFAIPLWPFYSHSAETVESCLAKPHTENSFTÎWWKDDKTLDR 
(2206 TO 3480)YANYEGCLWNATGVWCTGDETQCYGTWVPIGLAIPENEGGGSEGGGSEGGGSEGGGT
KPPEYGDTPIPGYTYIÎSÎPLDGTYPPGTEQNPANPNPSLEESQPLNTFMFQK1NRFRNRQ
GALTVYTGTVTQGTDPVKTYŸ'QYTPVSSKAMYDAYWNGKFRDCAFHSGFNEDPFVCEY
QGQSSDLPQPPVNAGGGSGGGSGGGSEGGGSEGGGSEGGGSEGGGSGGGSGSGDFDYE
KMANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGFIGDVSGLANGNGATCDF
AGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPYVFGAGKPYEFSIDCDKINLF
Genome of the bacteriophage fd (Inoviridae), 6408 bp of circular DNA[Beck,E.,. e t  a l 1993, Nucleic Acids Res. 5 (12), 4495-4503 (1978)]
GENE TRN8LATI0N
GENE 11= "MIDMLVLRLPFIDSLVCSRLSGNDLIAFVDLSKIATLSGMNLSARTVE 
(226 - 1458)YHIDGDLTVSGLSHPFESLPTHYSGIAFKIYEGSKNFYPCVEIKASPAKVLQGHNVFG 
TTDLALCSEALLUSIFANSLPCLYDLLDVNATTISRIDATFSARAPNENIAKQVIDHLR 
NVSNGQTKSTRSQNWESTVTWNETSRHRTLVAYLKHVELQHQIQQLSSKPSAKMTSYQ 
KEQLKVLSNPDLLEFASGLVRFEARIETRYLKSFGLPENLFDAIRFASDYNRQGKDLI 
FDLWSFSFSELFKAFEGDSMNIYDDSAVLDAIQSKHFTITPSGKTSFAKASRYFGFYR 
RLVNEGYDSVALTMPRNSFWRYVSALVECGIPKSQEiyiNLSTCNNWPLVRFINVDFSS 
QRPDWYNEPVLKIA"
GENE X="MNIYDDSAVLDAIQSKHFTITPSGKTSFAIG\SRYFGFYRKLVNEGYDSV 
(1123 TO 1458)ALIMPRNSFWRYVSALVECGIPKSQEMNLSTCNNVVPLVRFINVDFSSQRPDW 
YNEPVUKIA"
GENE V= "MIKAÆ1IKPSQAQFTTRSGVSRQGKPYSLNEQLCYVDLGNEYPVLVKITL 
( 1 4 7 0  TO 1 7 3 3 )DEGQPAYAPGLYTVHLSSFKVGQFGSLMIDRLRLVPAK"
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RGVFAFLLYVATFMYVFSTFANILRNKES "
GENE V I="MPVLLGIPLLLRFLGFLLVTLFGYLLTFLICKGFGKIAIAISLFLALII 
(3483 TO 3821)GLNSILVGYLSDISAQLPSDFVQGVQLILPSNALPCFYVILSVIGVAIFIFDVKQKIVS
YLDWDK"
GENE 1= "MAVYFVTGKLGSGKTLVSVGKIQDKIVAGCKIATNLDLRLQNLPQVGRF 
(3824 TO 4870)AKTPRVLRIPDKPSISDLLAIGRGNDSYDENKNGLLVLDECGTWFNTRSWNDKERQPI
IDWFLHARKLGWDIIFLVQDLSIVDKQARSALAEHWYCRRLDRITLPFVGTLYSLVT
GSKMPLPKLHVGWKYGDSQLSPTVERWLYTGKNLYNAYDTKQAFSSNYDSGVYSYLT
PYLSHGRYFKPLNLGQKMKLTKIYLKKFSRVLCLAIGFASAFTYSYITQPKPEVKKW
SQTYDFDKFTIDSSQRLNLSYRYVFKDSKGIGl.INSDDLQKQGYSITYIDLC'IVSIKKG
NSNEIVKCN"
GENE IV= 'WOjLNVINFWllMFVSSSSFAQVIEMNNSPLRDFVTiAfYSKQTGESVIV 
(4848 TO 6128)SPDVKGTVTVYSSDVKPENLRNFFISVLRANNFDMVGSIPSIIQKYNPNSQDYIDELP 
SSDIQEYDDNSAPSGGFFVPQNDNVTQTFKIMWRAKDLIRWELFVKSNTSKSSNVL 
SVDGSNLLWSAPKDILDNLPQFLSTVDLPTDQILIEGLIFEVQQGDALDFSFAAGSQ 
RGTVAGGVWTDRLTSVLSSAGGSFGIFNGDVLGLSVRALKTWSHSKILSVPRILTLSG 
QKGSISVGQNVPFITGRVTGESANVNNPFQTVERQNVGISMSVFPVAMAGGNXVLDIT 
SKADSLSSSTQASDVITNQRSIATTVNLRDGQTLLLGGLTDYKNTSQDSGVPFLSKIP 
LIGLLFSSRSDSNEESTLYVLVKATIVRAL "
NUCLEOTIDE SEQUENCE
V00602 Length: 6408 November 11, 1997 14:32 Type: N Check: 5529 
1 AATAGTGGAC TCTTGTTCCA AACTGGAACA ACACTCACAA CTAACTCGGC 
51 CTATTCTTTT GATTTATAAG GATTTTTGTC ATTTTCTGCT TACTGGTTAA 
101 AAAATAAGCT GATTTAACAA ATATTTAACG CGAAATTTAA CAAAACATTA 
151 ACGTTTACAA TTTAAATATT TGCTTATACA ATCATCCTGT TTTTGGGGCT 
201 TTTCTGATTA TCAACCGGGG TACATATGAT TGACATGCTA GTTTTACGAT 
251 TACCGTTCAT CGATTCTCTT GTTTGCTCCA GACTTTCAGG TAATGACCTG 
301 ATAGCCTTTG TAGACCTCTC AAAAATAGCT ACCCTCTCCG GCATGAATTT 
351 ATCAGCTAGA ACGGTTGAAT ATCATATTGA CGGTGATTTG ACTGTCTCCG 
401 GCCTTTCTCA CCCGTTTGAA TCTTTGCCTA CTCATTACTC CGGCATTGCA
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451 TTTAAAATAT ATGAGGGTTC TAAAAATTTT TATCCCTGCG TTGAAATTAA .1
501 GGCTTCACCA GCAAAAGTAT TACAGGGTCA TAATGTTTTT GGTACAACCG 1
551 ATTTAGCTTT ATGCTCTGAG GCTTTATTGC TTAATTTTGC TAACTCTCTG
601 CCTTGCTTGT ACGATTTATT GGATGTTAAC GCTACTACCA TTAGTAGAAT 1-
651 TGATGCCACC TTTTCAGCTC GCGCCCCAAA TGAAAATATA GCTAAACAGG
. ■
701 TTATTGACCA TTTGCGAAAT GTATCTAATG GTCAAACTAA ATCTACTCGT
751 TCGCAGAATT GGGAATCAAC TGTTACATGG AATGAAACTT CCAGACACCG I
801 TACTTTAGTT GCATATTTAA AACATGTTGA ACTACAGCAC CAGATTCAGC
851 AATTAAGCTC TAAGCCATCC GCAAAAATGA CCTCTTATCA AAAGGAGCAA
901 TTAAAGGTAC TGTCTAATCC TGACCTGTTG GAATTTGCTT CCGGTCTGGT
951 TCGCTTTGAG GCTCGAATTG AAACGCGATA TTTGAAGTCT TTCGGGCTTC
1001 CTCTTAATCT TTTTGATGCA ATTCGCTTTG CTTCTGACTA TAATAGACAG
1051 GGTAAAGACC TGATTTTTGA TTTATGGTCA TTCTCGTTTT CTGAACTGTT
1101 TAAAGCATTT GAGGGGGATT CAATGAATAT TTATGACGAT TCCGCAGTAT '1
1151 TGGACGCTAT CCAGTCTAAA CATTTTACAA TTACCCCCTC TGGCAAAACT
1201 TCCTTTGCAA AAGCCTCTCG CTATTTTGGT TTCTATCGTC GTCTGGTTAA
1251 TGAGGGTTAT GATAGTGTTG CTCTTACCAT GCCTCGTAAT TCCTTTTGGC 1
1301 GTTATGTATC TGCATTAGTT GAGTGTGGTA TTCCTAAATC TCAATTGATG , ■
1351 AATCTTTCCA CCTGTAATAA TGTTGTTCCG TTAGTTCGTT TTATTAACGT
1401 AGATTTTTCC TCCCAACGTC CTGACTGGTA TAATGAGCCA GTTCTTAAAA :
1451 TCGCATAAGG TAATTCAAAA TGATTAAAGT TGAAATTAAA CCGTCTCAAG I
1501 CGCAATTTAC TACCCGTTCT GGTGTTTCTC GTCAGGGCAA GCCTTATTCA
1551 CTGAATGAGC AGCTTTGTTA CGTTGATTTG GGTAATGAAT ATCCGGTGCT
1601 TGTCAAGATT ACTCTCGACG AAGGTCAGCC AGCGTATGCG CCTGGTCTGT
1651 ACACCGTGCA TCTGTCCTCG TTCAAAGTTG GTCAGTTCGG TTCTCTTATG
1701 ATTGACCGTC TGCGCCTCGT TCCGGCTAAG TAACATGGAG CAGGTCGCGG
1751 ATTTCGACAC AATTTATCAG GCGATGATAC AAATCTCCGT TGTACTTTGT
1801 TTCGCGCTTG GTATAATCGC TGGGGGTCAA AGATGAGTGT TTTAGTGTAT
1851 TCTTTCGCCT CTTTCGTTTT AGGTTGGTGC CTTCGTAGTG GCATTACGTA
1901 TTTTACCCGT TTAATGGAAA CTTCCTCATG AAAAAGTCTT TAGTCCTCAA
1951 AGCCTCCGTA GCCGTTGCTA CCCTCGTTCC GATGCTGTCT TTCGCTGCTG
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2001 AGGGTGACGA TCCCGCAAAA GCGGCCTTTG ACTCCCTGCA AGCCTCAGCG
2051 ACCGAATATA TCGGTTATGC GTGGGCGATG GTTGTTGTCA TTGTCGGCGC
2101 AACTATCGGT ATCAAGCTGT TTAAGAAATT CACCTCGAAA GCAAGCTGAT
2151 AAACCGATAC AATTAAAGGC TCCTTTTGGA GCCTTTTTTT TTGGAGATTT
2201 TCAACGTGAA AAAATTATTA TTCGCAATTC CTTTAGTTGT TCCITTCTAT
2251 TCTCACTCCG CTGAAACTGT TGAAAGTTGT TTAGCAAAAC CTCATACAGA
2301 AAATTCATTT ACTAACGTCT GGAAAGACGA CAAAACTTTA GATCGTTACG
2351 CTAACTATGA GGGCTGTCTG TGGAATGCTA CAGGCGTTGT GGTTTGTACT
2401 GGTGACGAAA CTCAGTGTTA CGGTACATGG GTTCCTATTG GGCTTGCTAT
2451 CCCTGAAAAT GAGGGTGGTG GCTCTGAGGG TGGCGGTTCT GAGGGTGGCG
2501 GTTCTGAGGG IGGCGGTACT AAACCTCCTG AGTACGGTGA TACACCTATT
2551 CCGGGCTATA CTTATATCAA CCCTCTCGAC GGCACTTATC CGCCTGGTAC
2601 TGAGCAAAAC CCCGCTAATC CTAATCCTTC TCTTGAGGAG TCTCAGCCTC
2651 TTAATACTTT CATGTTTCAG AATAATAGGT TCCGAAATAG GCAGGGTGCA
2701 TTAACTGTTT ATACGGGCAC TGTTACTCAA GGCACTGACC CCGTTAAAAC
2751 TTATTACCAG TACACTCCTG TATCATCAAA AGCCATGTAT GACGCTTACT
2801 GGAACGGTAA ATTCAGAGAC TGCGCTTTCC ATTCTGGCTT TAATGAGGAT
2851 CCATTCGTTT GTGAATATCA AGGCCAATCG TCTGACCTGC CTCAACCTCC
2901 TGTCAATGCT GGCGGCGGCT CTGGTGGTGG TTCTGGTGGC GGCTCTGAGG
2951 GTGGCGGCTC TGAGGGTGGC GGTTCTGAGG GTGGCGGCTC TGAGGGTGGC
3001 GGTTCCGGTG GCGGCTCCGG TTCCGGTGAT TTTGATTATG AAAAAATGGC
3051 AAACGCTAAT AAGGGGGCTA TGACCGAAAA TGCCGATGAA AACGCGCTAC
3101 AGTCTGACGC TAAAGGCAAA CTTGATTCTG TCGCTACTGA TTACGGTGCT
3151 GCTATCGATG GTTTCATTGG TGACGTTTCC GGCCTTGCTA ATGGTAATGG
3201 TGCTACTGGT GATTTTGCTG GCTCTAATTC CCAAATGGCT CAAGTCGGTG
3251 ACGGTGATAA TTCACCTTTA ATGAATAATT TCCGTCAATA TTTACCTTCT
3301 TTGCCTCAGT CGGTTGAATG TCGCCCTTAT GTCTTTGGCG CTGGTAAACC
3351 ATATGAATTT TCTATTGATT GTGACAAAAT AAACTTATTC CGTGGTGTCT
3401 TTGCGTTTCT TTTATATGTT GCCACCTTTA TGTATGTATT TTCGACGTTT
3451 GCTAACATAC TGCGTAATAA GGAGTCTTAA TCATGCCAGT TCTTTTGGGT
3501 ATTCCGTTAT‘ TATTGCGTTT CCTCGGTTTC CTTCTGGTAA CTTTGTTCGG
3551 CTATCTGCTT' ACTTTCCTTA, AAAAGGGCTT CGGTAAGATA. GCTATTGCTA
A p p e n d i c e s
3601 TTTCATTGTT TCTTGCTCTT ATTATTGGGC TTAACTCAAT TCTTGTGGGT 
3651 TATCTCTCTG ATATTAGCGC ACAATTACCC TCTGATTTTG TTCAGGGCGT 
3701 TCAGTTAATT CTCCCGTCTA ATGCGCTTCC CTGTTTTTAT GTTATTCTCT 
3751 CTGTAAAGGC TGCTATTTTC ATTTTTGACG TTAAACAAAA AATCGTTTCT 
3801 TATTTGGATT GGGATAAATA AATATGGCTG TTTATTTTGT AACTGGCAAA 
3851 TTAGGCTCTG GAAAGACGCT CGTTAGCGTT GGTAAGATTC AGGATAAAAT 
3901 TGTAGCTGGG TGCAAAATAG CAACTAATCT TGATTTAAGG CTTCAAAACC 
3951 TCCCGCAAGT CGGGAGGTTC GCTAAAACGC CTCGCGTTCT TAGAATACCG 
4001 GATAAGCCTT CTATTTCTGA TTTGCTTGCT ATTGGTCGTG GTAATGATTC 
4051 CTACGACGAA AATAAAAACG GTTIGCTTGT TCTTGATGAA TGCGGTACTT 
4101 GGTTTAATAC CCGTTCATGG AATGACAAGG AAAGACAGCC GATTATTGAT 
4151 TGGTTTCTTC ATGCTCGTAA ATTGGGATGG GATATTATTT TTCTTGTTCA 
4201 GGATTTATCT ATTGTTGATA AACAGGCGCG TTCTGCATTA GCTGAACACG 
4251 TTGTTTATTG TCGCCGTCTG GACAGAATTA CTTTACCCTT TGTCGGCACT 
4301 TTATATTCTC TTGTTACTGG CTCAAAAATG CCTCTGCCTA AATTACATGT 
4351 TGGTGTTGTT AAATATGGTG ATTCTCAATT AAGCCCTACT GTTGAGCGTT 
4401 GGCTTTATAC TGGTAAGAAT TTATATAACG CATATGACAC TAAACAGGCT 
4451 TTTTCCAGTA ATTATGATTC AGGTGTTTAT TCATATTTAA CCCCTTATTT 
4501 ATCACACGGT CGGTATTTCA AACCATTAAA TTTAGGTCAG AAGATGAAAT 
4551 TAACTAAAAT ATATTTGAAA AAGTTTTCTC GCGTTCTTTG TCTTGCGATA 
4601 GGATTTGCAT CAGCATTTAC ATATAGTTAT ATAACCCAAC CTAAGCCGGA 
4651 GGTTAAAAAG GTAGTCTCTC AGACCTATGA TTTTGATAAA TTCACTATTG 
4701 ACTCTTCTCA GCGTCTTAAT CTAAGCTATC GCTATGTTTT CAAGGATTCT 
4751 AAGGGAAAAT TAATTAATAG CGACGATTTA CAGAAGCAAG GTTATTCCAT 
4801 CACATATATT GATTTATGTA CTGTTTCAAT TAAAAAAGGT AATTCAAATG 
4851 AAATTGTTAA ATGTAATTAA TTTTGTTTTC TTGATGTTTG TTTCATCATC 
4901 TTCTTTTGCT CAAGTAATTG AAATGAATAA TTCGCCTCTG CGCGATTTCG 
4951 TGACTTGGTA TTCAAAGCAA ACAGGTGAAT CTGTTATTGT CTCACCTGAT 
5001 GTTAAAGGTA CAGTGACTGT ATATTCCTCT GACGTTAAGC CTGAAAATTT 
5051 ACGCAATTTC TTTATCTCTG TTTTACGTGC TAATAAÏTTT GATATGGTTG 
5101 GCTCAATTCC TTCCATAATT CAGAAATATA ACCCAAATAG TCAGGATTAT
A p p e n d i c e s ______________________ 1 2  0
5151 ATTGATGAAT TGCCATCATC TGATATTCAG GAATATGATG ATAATTCCGC
5201 TCCTTCTGGT GGTTTCTTTG TTCCGCAAAA TGATAATGTT ACTCAAACAT 1
5251 TTAAAATTAA TAACGTTCGC GCAAAGGATT TAATAAGGGT TGTAGAATTG .f
5301 TTTGTTAAAT CTAATACATC TAAATCCTCA AATGTATTAT CTGTTGATGG
5351 TTCTAACTTA TTAGTAGTTA GCGCCCCTAA AGATATTTTA GATAACCTTC 1
5401 CGCAATTTCT TTCTACTGTT GATTTGCCAA CTGACCAGAT ATTGATTGAA ■£
5451 GGATTAATTT TCGAGGTTCA GCAAGGTGAT GCTTTAGATT TTTCCTTTGC 1
5501 TGCTGGCTCT CAGCGCGGCA CTGTTGCTGG TGGTGTTAAT ACTGACCGTC
5551 TAACCTCTGT TTTATCTTCT GCGGGTGGTT CGTTCGGTAT TTTTAACGGC
5601 GATGTTTTAG GGCTATCAGT TCGCGCATTA AAGACTAATA GCCATTCAAA
5651 AATATTGTCT GTGCCTCGTA TTCTTACGCT TTCAGGTCAG AAGGGTTCTA s
5701 TTTCTGTTGG CCAGAATGTC CCTTTTATTA CTGGTCGTGT AACTGGTGAA
5751 TCTGCCAATG TAAATAATCC ATTTCAGACG GTTGAGCGTC AAAATGTTGG
5801 TATTTCTATG AGTGTTTTTC CCGTTGCAAT GGCTGGCGGT AATATTGTTT %
5851 TAGATATAAC CAGTAAGGCC GATAGTTTGA GTTCTTCTAC TCAGGCAAGT 1
5901 GATGTTATTA CTAATCAAAG AAGTATTGCG ACAACGGTTA ATTTGCGTGA
5951 TGGTCAGACT CTTTTGCTCG GTGGCCTCAC TGATTACAAA AACACTTCTC
6001 AAGATTCTGG TGTGCCGTTC CTGTCTAAAA TCCCTTTAAT CGGCCTCCTG 1
6051 TTTAGCTCCC GTTCTGATTC TAACGAGGAA AGCACGTTGT ACGTGCTCGT
6101 CAAAGCAACC ATAGTACGCG CCCTGTAGCG GCGCATTAAG CGCGGCGGGT
6151 GTGGTGGTTA CGCGCAGCGT GACCGCTACA CTIGCCAGCG CCCTAGCGCC
6201 CGCTCCTTTC GCTTTCTTCC CTTCCTTTCT CGCCACGTTC TCCGGCTTTC
6251 CCCGTCAAGC TCTAAATCGG GGGATCCCTT TAGGGTTCCG ATTTAGTGCT
6301 TTACGGCACC TCGACCTCCA AAAACTTGAT TTGGGTGATG GTTCACGTAG
6351 TGGGCCATCG CCCTGATAGA CGGTTTTTCG CCCTTTGACG TTGGAGTCCA
6401 CGTTCTTT
